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PEP TALK 1
PEP and its uses
This report presents the ﬁndings from a study investigating homosexually active men’s awareness 
and access to post-exposure prophylaxis (PEP) following potential sexual exposure to HIV. The 
study consisted of two arms. In the ﬁrst, identical questions on PEP were asked in the Gay Men’s Sex 
Survey in 2003 and 2005 to examine population level and sub-group changes in awareness over a 
period where the public proﬁle of PEP was increased. In the second part, men who had at least one 
experience of attempting to access PEP took part in detailed one-to-one interviews. This qualitative 
data oﬀers a detailed insight into men’s awareness of the treatment, what prompted them to seek 
help, their satisfaction with the clinical experience and follow-up, and their subsequent behavioural 
intentions and practices in relation to HIV risk. 
The remainder of this chapter oﬀers a brief introduction to PEP and its use, by reviewing existing 
academic research and commentary on PEP (mainly focussing on its use outside of the occupational 
setting). It also provides background information on developments relating to PEP following sexual 
exposure in the UK context. Chapter 2 presents the quantitative data, and Chapter 3 presents a 
thematic analysis of the information gained from the one-to-one interviews. In the ﬁnal chapter, we 
present conclusions drawn from the ﬁndings of both arms of this investigation, as well as practical 
recommendations regarding meeting the PEP-related needs of individual men at risk of HIV 
exposure, and the needs of professionals working towards full implementation of the UK guidelines 
on PEP following sexual exposure to HIV.
1.1  INTRODUCTION TO PEP
The notion of using anti-retroviral therapies to prevent HIV sero-conversion emerged following 
on from laboratory and animal testing of the technology for its eﬃcacy in various transmission 
settings (Tsai et al. 1998, Otten et al. 2000) and its highly eﬀective use in the prevention of mother-
to-child transmission. As scientiﬁc understanding of the pathogenesis of HIV has improved, it has 
been possible to hypothesise about the best uses of available anti-retroviral medications as post-
exposure prophylaxis (PEP). Immediately following HIV exposure, there is an infection of dentritic 
cells at the site where exposure occurred. Those infected cells then travel to the nearest set of lymph 
nodes during the 24-48 hour period immediately following exposure. The theory behind the use 
of PEP is to halt the onward development and ‘settlement’ of HIV infected cells within the lymph 
system (and onward to a full systemic infection) by initiating anti-retroviral treatment during that 
brief window of time that is available before systemic infection takes place (Almeda et al. 2004). 
There is some variation in views on how long that initial window period is, with some protocols 
disallowing access to PEP where a patient presents more than 36 hours after exposure (Ende et 
al. 2006), while others allow for treatment up to 72 hours later (Centres for Disease Control and 
Prevention 2005, Fisher et al. 2006). All existing protocols recommend that treatment is maintained 
consistently for twenty eight days. Evidence from animal and human studies demonstrate that the 
sooner the PEP is initiated, the higher the likelihood of success (Tsai et al. 1998, Roland et al. 2005).
Protocols for the use of PEP following needle-stick injuries sustained by healthcare and emergency 
services staﬀ in the occupational setting have been developed and implemented on a widespread 
basis (Rey et al. 2000). However, across the developed world (where access to anti-retroviral 
medication is relatively aﬀordable and accessible), access to PEP following sexual exposures 
(sometimes referred to as PEPSE) has been much more sporadic, and it would still be diﬃcult to 
argue that there is scientiﬁc or medical consensus on its use. France instituted national guidelines 
for PEP following sexual exposure in 1998, yet in other locations, guidelines were not introduced 
until 2001 (Australia), 2005 (United States) and 2006 (UK), and some countries (ie. Canada) remain 
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without national guidelines regarding exposures that are not occupational. While the debate 
about the scientiﬁc basis for the use of PEP following sexual exposure continues, existing national 
guidelines advance the notion that in the absence of randomised control trials, there is a strong 
enough biological argument on which to base an expectation of eﬃcacy. 
1.2  ACADEMIC AND PRACTITIONER DEBATES
In this section we brieﬂy highlight some of the central issues arising from scientiﬁc and practical 
discourses about the use of PEP following sexual exposure as they relate to the themes arising from 
the research ﬁndings presented in subsequent chapters. More detailed reviews on these topics are 
also available elsewhere (Pinkerton et al. 2004, Almeda et al. 2004, Centers for Disease Control and 
Prevention 2005, Fisher et al. 2006).
The most frequently cited studies on PEP following sexual exposure took place in Brazil and the 
USA. In one Brazilian project, homosexually active men were given PEP supplies to commence 
immediately after sexual exposure (Schecter et al. 2002), whereas in the other, HIV outcomes for 
men who received PEP within the 72 hour period were compared to those who presented later 
(Schecter 2002). In both these studies, men who took PEP following potential sexual exposure to HIV 
were less likely to sero-convert than men who had not. 
The other key project in this area is referred to as the San Francisco PEP Study, which explicitly did 
not set out to examine eﬃcacy (as in the Brazilian work). Instead, articles emanating from the San 
Francisco study report on feasibility of accessing PEP among those at high risk of transmission (Kahn 
et al. 2001), cost eﬀectiveness of treatment (Pinkerton et al. 2004) and subsequent behavioural 
impact (Martin et al. 2004). This collection of articles provide an underpinning for the development 
of an evidence base on the implementation of PEP following sexual exposure from the point of view 
of epidemic impact. They sustain strong arguments for the judicious use of PEP following occasions 
where it is either established or likely that the source patient is HIV infected. 
Kahn et al. (2004) report that the use of PEP following sexual exposure is feasible and acceptable 
within communities where HIV is prevalent, and that in most instances, those seeking PEP described 
a lapse in their usually cautious sexual practices, rather than habitual high-risk behaviour. This latter 
ﬁnding is supported by a study undertaken in Australia which will be discussed in greater detail 
below (Körner et al. 2003, 2005). 
One of the concerns raised by health practitioners has been the extent to which oﬀering PEP 
following sexual exposure will increase the strain on service provision and already escalating 
treatment costs at a local level (Richens et al. 2005). Fisher (2005) responds directly to this concern 
by highlighting that cost arguments are not queried in relation to treatment following occupational 
exposures, despite much lower risks of transmission in these circumstances, and that modelling 
studies have demonstrated that PEP following sexual exposure is cost saving when appropriately 
administered. He refers here to the work of Pinkerton and colleagues (2004), who assessed cost 
eﬀectiveness outcomes for 96 diﬀerent metropolitan areas in the United States, recognising that 
local HIV prevalence rates would impact on the costs per transmission averted. They found that 
cost eﬀectiveness increased with improved targeting of people involved in high-risk exposures, 
particularly those where the source was known to have HIV, and that PEP following receptive anal 
intercourse was cost eﬀective in all metropolitan areas, regardless of whether the source was known 
to have HIV.
Another key issue that is raised in relation to PEP following sexual exposure is the extent to which it 
could contribute to a so-called ‘optimistic bias’ eﬀect on sexual behaviour, to the extent that those 
who know about PEP might be more likely to engage in sexual behaviour that carries a high risk of 
HIV transmission as a direct result of that awareness. 
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We believe there is a distinct danger that the promotion of PEPSE could reinforce rising 
trends in sexual behaviour and might add to, rather than lessen, HIV transmission.
(Richens, Edwards & Sadiq 2005: 190-191)
However, this claim is refuted by a range of research investigations which have demonstrated 
that this type of simplistic relationship between PEP awareness and risk behaviour does not exist. 
Quantitative research undertaken in the United States to address this question has used a range 
of methods. Results from a survey conducted among an opportunistic sample of Gay men in San 
Franciso (Waldo et al. 2000) indicated that knowing about PEP at all may have increased men’s 
likelihood of engaging in unprotected anal intercourse (UAI), but that knowing that PEP was 
available locally did not – again, challenging notions of a straightforward relationship between 
knowledge and behaviour. Those analysing twelve month follow-up records from the San Francisco 
PEP Study noted that those with a high level of risk behaviour at baseline (before being prescribed 
PEP) were the most likely to gradually revert to prior behaviours, but that PEP access was not an 
independent inﬂuence on subsequent behaviour (Martin et al. 2004). The authors point out that this 
is not a surprising ﬁnding within a context where 41% of respondents reported a high risk of being 
exposed to HIV within the three months before their initial request for PEP. This chimes with other 
studies demonstrating that HIV high risk behaviour may neither increase nor decrease HIV infection 
among those who have taken PEP (Grulich et al. 2006). One randomised control trial that tested the 
eﬀectiveness of standard versus enhanced risk reduction counselling for individuals on PEP (Roland 
et al. 2006) found that enhanced provision (ﬁve counselling sessions as opposed to two) was most 
eﬀective for those with the highest baseline level of risk.
1.3   HEALTH PROFESSIONALS’ AWARENESS AND PRESCRIPTION OF PEP 
FOLLOWING SEXUAL EXPOSURE
Research that explores knowledge, behaviour and attitudes relating to PEP following sexual 
exposure usually concentrates on the views of doctors. While being aware of the time-sensitivity of 
much of the work in this area, various research teams have sought to establish the extent to which 
doctors working variously in General Practice, Accident and Emergency departments, and other 
hospital settings were aware of PEP either for occupational exposures, non-occupational exposures, 
or both (the conﬁguration of diﬀerent national and regional health care systems will dictate the 
extent to which these diﬀerent types of practitioners would encounter patients with concerns about 
HIV exposure). In most instances, it has been demonstrated that professionals’ knowledge of PEP 
and its diﬀerent applications is patchy at best. For example, in 1998 a postal survey of 273 junior 
doctors in two teaching hospitals in London, found that while the vast majority of respondents 
knew of the existence of PEP, just under one third did not know the recommended time period 
in which it should be administered (Chen et al. 2001). A study undertaken among GPs in Sydney, 
Australia in 2002 (Ooi et al. 2004) demonstrated that more than two thirds were aware of the use 
of PEP following occupational exposures, while only a third had heard of its use following sexual 
exposure. 
It has been demonstrated that the introduction of national guidelines for the provision of PEP after 
non-occupational exposures contribute to the improvement of HIV specialists’ attitudes towards 
prescribing treatment following voluntary sexual exposure (Laporte et al. 2002), yet this impact 
would not seem to be replicated in studies that focus on the practices of doctors in emergency 
department settings. Among an opportunistic sample of 600 Emergency practitioners (Merchant 
& Keshavarz 2003), 68% had administered PEP, with the vast majority of those cases relating to 
occupational exposure. A distinct diﬀerence was noted between the numbers of those reporting 
PEP following non-consensual sex (48%) and consensual sex (8%). This diﬀerential treatment might 
be bolstered in some settings by protocols to treat all penetrative sexual assault cases with PEP. 
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A further study conducted among Emergency Departments in New York State found that 65.3% 
of sexual assault exposures that presented in 2005 were treated with PEP, but that only 42.7% of 
so called ‘voluntary exposures’ were similarly treated (Ende et al. 2006). It would seem clear that 
attitudes about ‘innocent’ and ‘guilty’ victims of HIV exposure remain entrenched in discourses and 
policies pertaining to PEP at a professional level. As one commentator notes:
Most health care workers are empathetic to a colleague who sustained a work-related injury. 
This empathy, however, may not extend to an individual who has participated in a high-risk 
activity. Although physicians may not condone the behaviours exhibited by an individual 
with non-occupational exposures, they continue to have an obligation to act in the best 
interest of the patient. PEP should be considered as one of the therapies available to this 
population when they have an isolated, high-risk exposure to HIV.
(Spence 2003: 5)
Given the disproportionate concern surrounding community and occupational exposures to HIV it is 
not surprising that some doctors with both HIV specialist and emergency care backgrounds have a 
tendency to prescribe PEP when it is not warranted (Braitstein et al. 2002, Laporte et al. 2002, Patel et 
al. 2002).
1.4   HOMOSEXUALLY ACTIVE MEN’S AWARENESS AND EXPERIENCES OF PEP 
FOLLOWING SEXUAL EXPOSURE
In contrast to the existing literature on doctors and PEP following sexual exposure, there is 
comparatively little known about the PEP-related knowledge, attitudes and behaviours of 
individuals most at risk of HIV exposure. The work that does exist focuses on homosexually active 
men, which is unsurprising considering the epidemiological proﬁles of most countries where PEP is 
aﬀordable and available. 
Among populations of homosexually active men, awareness and access to PEP following sexual 
exposure is contingent on the existence of local and national protocols, and the extent to which 
community information campaigns have been successful. For instance, the small scale survey 
study by Waldo, Stall and Coates (2000), sampled Gay men in San Francisco community settings 
before and after a high proﬁle PEP campaign in that city. Despite the limitations of a small sample 
size (n= 295 at Time 1, and n=234 at Time 2), the ﬁndings demonstrated that 58% were aware of 
the concept of PEP following sexual exposure at baseline, which increased to 70% following the 
intervention. This study was undertaken long before the implementation of national guidelines on 
PEP following sexual exposure in the United States. In contrast, a prospective cohort study of HIV 
negative homosexually active men, started in Sydney in 2001, found that men’s awareness of PEP at 
the outset was 78.5%, which increased to 97.4% by the time of the fourth annual interview (Grulich 
et al. 2006). Guidelines recommending the use of PEP following non-occupational exposures were 
introduced in New South Wales in 1998, and across Australia in 2001.
A qualitative study also undertaken in Sydney oﬀers signiﬁcant insight into the narratives, 
motivations, experiences and reﬂections of men who have taken PEP following sexual exposure 
(Körner et al. 2003, 2005). As part of a wider study in New South Wales that aims to monitor the 
implementation of guidelines on PEP following sexual exposure in Australia in 2001, those who had 
received PEP were invited to take part in an interview arm, designed to establish the circumstances 
under which PEP was requested and the impact of prescribing PEP on behavioural intentions 
(Körner et al. 2003). Of the 84 respondents, a total of 77 were homosexually active men. One of the 
central ﬁndings of this work was that PEP was used as a means of reclaiming control over unusual 
situations that had resulted in unexpected exposure to HIV among individuals who tended to have 
a low baseline level of sexual risk. 
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One theme which runs like a leitmotif through all the issues raised in the interviews is that 
of control: control over sexual practices; control in the post-exposure period; control over 
decision making processes and disclosure; and taking control in the future. 
(Körner et al. 2003:10)
Many of the men in this sample described sexual contexts and situations that were outside of their 
own norms, some had just broken up with long term partners, or they had sex at a house that wasn’t 
their own, or they were dealing with stress in other areas of their lives. To this extent, potential HIV 
exposure came as a surprise to them, and accessing PEP was at least in part a means of restoring 
order. Men described feelings of shame and stupidity about the circumstances that led to their 
exposure, which posed a signiﬁcant barrier to telling others about being on PEP.
PEP for sexual exposure involves much more than unprotected intercourse and a four-week 
course of anti-retroviral drugs. It entails admitting mistakes, failure, bad luck, losing control, 
disappointment for letting one’s standards drop, acting in spite of one’s better knowledge 
and dealing with emotions of anger and anxiety. 
(Körner et al. 2003: 48)
Men in this study tended to feel that the experience had helped them to realise that HIV exposures 
don’t only happen to others, that they too were vulnerable. Given that interviews were held within 
six months of men’s exposure experiences, it was not possible to determine the longer term 
behavioural impact, but most expressed a desire to avoid HIV exposure in the future. 
Nonetheless, it is also worth bearing in mind that a separate piece of quantitative research also 
undertaken in Sydney found that men who had been prescribed PEP continued to be at high risk of 
subsequent HIV infection (Grulich et al. 2006). Here, analysis demonstrated that during the course 
of their participation in an ongoing cohort study (started in 2001) men who had ever received PEP 
were 2.82 times more likely to become infected with HIV than men who had not received PEP.
1.5 PEP FOLLOWING SEXUAL EXPOSURE IN THE UK 
In order to place this research report in its context, it is important to highlight a number of events 
before, during and after the data collection period. These include: the inclusion of PEP-related aims 
in Making it Count (Hickson et al. 2003a); the development and publication of a UK prescribing 
guideline for PEP following sexual exposure; and a CHAPS campaign (in England and Wales) to 
increase awareness of PEP among homosexually active men. 
The National Strategy for Sexual Health and HIV (Department of Health 2001) does not mention 
post-exposure prophylaxis (PEP). Moreover, the Chief Medical Oﬃcers Expert Advisory Group 
on AIDS (EAGA) has stated that “it is aware that some physicians have prescribed PEP outside 
the occupational exposure context, on an individual case-by-case basis. However, due to lack 
of any evidence of eﬃcacy, at present EAGA cannot recommend in favour of, or against its use.” 
(Department of Health 2004, p 20). 
The current edition of Making it Count, the CHAPS HIV prevention strategy, includes targets 
concerning PEP (Hickson et al. 2003a). For the ﬁrst time in 2003 Making it Count included a 
population target of increasing the proportion of men who have sex with men (MSM) who are 
sexually exposed to HIV who take PEP within 72 hours of exposure. Making it Count also outlines 
a number of needs men who have been sexually exposed to HIV have related to accessing PEP, 
including: 
• awareness of PEP; 
• the existence of accessible, acceptable and eﬀective PEP prescribing services; 
• knowledge of and trust in local PEP services; and
• understanding of the potential and limitations of PEP. 
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Making it Count also outlines the needs men who access PEP have that are related to the successful 
completion of the course of drugs, including: 
• knowledge of how the drugs work and the importance of completing the course to their eﬃcacy; 
• clinical monitoring for side-eﬀects; 
• space to talk over conﬂicting emotions about continuing taking the drugs versus the chance of 
becoming infected.
The research presented in this report concerns a number of these needs, starting with quantitative 
data about basic awareness of PEP’s existence and actual attempts to access and take PEP. While 
the latter are not direct measures of the proportion of men exposed to HIV who take PEP, they are 
general indicators of progress in this measure. Qualitative information was also collected in order 
to gain a more detailed understanding of men’s experiences relating to PEP. This has allowed us to 
gain considerable insight into the range and accessibility of PEP prescribing services, and the extent 
to which men who were prescribed PEP experienced clinical monitoring and support in terms of 
adherence, side eﬀects, psychological impact and behaviour change. 
In April 2004, the Clinical Eﬀectiveness Group within the British Association for Sexual Health 
and HIV (BASHH) released for consultation a draft set of guidelines on the administration and 
prescription of PEP following sexual exposure to HIV. BASHH is a professional representative body 
for sexual health professionals in the UK, including those involved in the management of STIs and 
HIV. The draft guidelines included a review of data to support the use of risk assessment frameworks, 
recommendations on when PEP should and should not be considered, the possible impact on 
sexual behaviour, cost eﬀectiveness and best practice service provision.
Between July and September 2004 the Terrence Higgins Trust ran a pilot multi-part education 
intervention about PEP targeting Gay men and Bisexual men, on behalf of the CHAPS partnership. 
The intervention was targeted at men resident in London and Brighton & Hove. It comprised four 
methods: 
•  Full-page colour adverts were displayed in the following local Gay community magazines and 
newspapers: QX (London), G-Scene (Brighton) and 3Sixty (Brighton). 
•  An educational leaﬂet was produced and distributed hand-to-hand by outreach workers and in 
leaﬂet racks on the Gay scene in both London and Brighton & Hove. The leaﬂet was also inserted 
in the July issue of QX magazine in London. 
•  A variety of promotional materials reﬂecting the campaign imagery were designed for use during 
outreach sessions, both as ice-breakers and reference items for men to take away and keep. 
Included were fridge magnets, sticks of rock, small wallet sized (A8) information cards and quiz 
cards (A6) in question and answer format. Bar-staﬀ were also oﬀered t-shirts with the campaign 
imagery. 
•  An internet micro-site was established which carried the advert and leaﬂets as well as a self-
administered risk assessment too. It also included a list of clinics known to prescribe PEP, a section 
for health professionals and some suggestions for community action in areas where PEP was not 
available. The website was promoted on all written materials and via banner adverts on  
www.Gaydar.co.uk
Evaluation of the intervention indicated it was acceptable to its target audience and eﬀective at 
increasing awareness and knowledge of PEP (Weatherburn 2005). 
In the summer of 2005 the same campaign was implemented across England and Wales. The same 
full-page colour adverts appeared in one weekly (Boyz) and ﬁve monthly (G-Scene, Gay Times, 
Out North West, Midland Zone and Bent) Gay media titles between June and August 2005. The 
educational leaﬂet was distributed nationally as were the promotional materials for use during 
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outreach. The internet micro-site was updated and additional investment in www.Gaydar.co.uk was 
purchased for its promotion.
It was not until February 2006 that the ﬁnalised version of the BASHH guidelines were published 
(Fisher et al. 2006), but in the interim it was expected that the draft document could function as a de 
facto framework to assist decision making on risk assessment and provision of PEP following sexual 
exposure. The text of the document did not change signiﬁcantly from its draft form apart from some 
clariﬁcation on what constitutes high prevalence communities for the purposes of risk assessment. 
The published guidelines made it very clear that the provision of this new technology should be 
situated within the broader context of HIV prevention strategies and sexual health. 
The writing committee feel it is crucial to consider PEPSE as only one strategy in preventing 
HIV infection and, as such, it should be considered as a last measure where conventional, and 
proven, methods of HIV prevention have failed.
(Fisher et al. 2006: 84)
In spite of the prior comments of the Chief Medical Oﬃcers Expert Advisory Group on AIDS 
(Department of Health 2004) the publication of these guidelines received direct support from the 
Chief Medical Oﬃcer. In April 2006, in a letter addressed to all Primary Care Trust Chief Executives 
and Directors of Strategic Health Authorities the Chief Medical Oﬃcer stated that: 
I would therefore ask you to ensure that PEP is a part of the spectrum of sexual health 
services for your local populations. 
(Donaldson 2006)
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Changes in PEP awareness, 
seeking and using
 
2.1 METHODS
The Gay Men’s Sex Survey (GMSS) is an annual, community-based, self-completion questionnaire 
generating data about HIV prevention risk behaviours and needs. Field work occurs from July to 
September each year. The survey changes each year, drawing on a stock of behavioural and needs 
indicators based on Making it Count (Hickson et al. 2003a). The survey is funded by the Terrence 
Higgins Trust as part of the CHAPS programme for England and Wales.
The survey is available to complete on-line and is promoted on two large commercial Gay web sites 
(Gaydar and Gay.com), and a large number of non-commercial Gay community web-sites. The survey 
is also available as an A6 booklet which is self-sealing and has a Freepost address for return to Sigma 
Research. These booklets are distributed by health promoters to men who have sex with men in a wide 
variety of settings during the course of their work. GMSS has occurred every year since 1997 – further 
details about the surveys can be found at www.sigmaresearch.org.uk/reports.html
In 2003, GMSS included a series of questions about PEP. Prior to the questions on PEP, respondents 
were presented with the following text: 
PEP is a one month course of anti-HIV drugs. It attempts to stop HIV infection taking place after a 
person is exposed to the virus. It should be taken as soon as possible after exposure and probably 
within a few days. In a few UK hospitals PEP is available for those exposed to HIV through sex. In 
those hospitals whether you get PEP will depend on the likelihood that you have been exposed to 
HIV and your ability to cope with the side eﬀects.
All respondents were then asked the following three questions: 
• Have you heard of Post-Exposure Prophylaxis (PEP)?
• Have you ever tried to get PEP?
• Have you ever taken PEP?
In addition, men who did not have diagnosed HIV were also asked: 
• If you thought you had been exposed to HIV would you consider trying to get PEP?
GMSS 2005 repeated the PEP questions from 2003. In 2004 the pilot CHAPS PEP campaign was 
targeted at men in London and Brighton and Hove. The intervention was rolled out nationally in 
mid-2005 (see section 1.5). GMSS 2003 predated any PEP-speciﬁc health promotion campaigns in 
the UK. GMSS 2005 occurred after the pilot implementation of the CHAPS PEP campaign targeting 
men resident in London and Brighton & Hove, and during the roll-out of the CHAPS PEP campaign 
across England and Wales. 
This chapter examines changes in PEP awareness and access, and the extent to which changes were 
geographically conﬁned and diﬀerential by the intervention target groups.
2
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2.2 SAMPLES DESCRIPTION
The following table presents the demographic descriptions of the samples across the two surveys 
using nine variables: recruitment method; residence; age; ethnicity; annual income; HIV testing 
history; current male relationship status; female sexual partner in the last year; and number of male 
sexual partners in the last year. Diﬀerences in awareness, seeking and taking PEP are described 
across these nine variables in the remainder of this chapter. 
Previous Gay Men’s Sex Surveys have demonstrated that the following sub-groups of homosexually 
active men are more likely to be involved in sexual HIV exposure (Hickson et al. 1998, Hickson et al. 
1999, Weatherburn et al. 2000, Hickson et al. 2001, Reid et al. 2002, Hickson et al. 2003b, Reid et al. 
2004, Weatherburn et al. 2005). 
Residence: men living in London and Brighton & Hove, where HIV prevalence is highest. 
Age: men under 40. The average age of HIV diagnosis among MSM in the UK is about 36 
years, so the average age of infection is some time before this.
Ethnicity: Black men, who are over-represented among homosexually active men with HIV in 
the UK and show higher levels of sexual risk behaviours.
Income: men with lower incomes show higher levels of sexual risk behaviours.
HIV testing history: Although men with diagnosed HIV are not expected to take PEP they are 
much more likely to be involved in sexual HIV exposure than uninfected men and are able to 
inform their sexual partners about PEP.
Female sexual partner in the last year: men who have sex with men only are over-
represented among men with HIV and show higher levels of sexual risk behaviour.
Number of male sexual partners in the last year: men with higher numbers of male sexual partners 
are over-represented among men with HIV and show higher levels of sexual risk behaviours.
While we have also demonstrated that men with lower levels of formal education are both more 
likely to be involved in HIV exposure and more likely to have HIV, identical measures of education 
were not used in GMSS 2003 and 2005. However, there is a close correlation between income 
and educational level (Reid et al. 2004) and the income data provides some insight into the likely 
relationship of educational achievement to the PEP variables that follow. 
In both years the internet accounted for three quarters of the sample with the booklet providing the 
other quarter. The proportion of men who had ever tested for HIV (55.9–56.5%) and the proportion 
who had tested HIV positive (6.3–6.5%) did not signiﬁcantly vary over the two years.
Compared to GMSS 2003, the 2005 sample included slightly smaller proportions of respondents 
in Wales, Scotland, Northern Ireland, North England and South England, and slightly higher 
proportions in Mid & Eastern England and London. Also the 2005 GMSS sample was signiﬁcantly 
older, more ethnically diverse, had higher incomes, were more likely to have a current regular male 
sexual partner and to have had fewer male sex partners in the last year but more likely to have had 
sex with a woman in the last year. These diﬀerences are outlined in the following table. 
In the following sections we report the proportion of men who were aware of, had sought and 
who had taken PEP, and the proportions in each demographic group who had done so. Chi-square 
was used to examine univariate diﬀerences. Within each year, odds ratios were examined to look at 
diﬀerences across each of the nine demographic variables, adjusted for the other eight. Within each 
demographic group, odds ratios were examined across the two years, adjusted for the diﬀerences 
between the two samples. This ensures that the reported diﬀerences between 2003 and 2005 are 
not a function of diﬀerences across the samples. 
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UK sample description
* = p<.01 (chi-squared) difference across the two years
2003 2005
total sample size 14551 16432
recruitment method (ns) web 74.2
10801/14551
75.0
12325/16432
booklet 25.8
3750/14551
25.0
4107/16432
missing n 0 0
Residence *
[nb. Booklets distributed in Scotland & N Ireland in 
2003 but not 2005 due to funding changes]
[nb. All cases missing Directorate of residence were 
known to live in the UK]
London 25.5
3434/13488
28.8
4350/15100
South England 19.6
2649/13488
18.2
2744/15100
Mid & Eastern England 19.5
2635/13488
20.1
3039/15100
North England 20.9
2820/13488
20.0
3015/15100
Wales 4.2
568/13488
3.9
584/15100
Scotland 7.7
1042/13488
7.1
1067/15100
N.Ireland 2.5
340/13488
2.0
301/15100
missing n 1063 1332
Age *
[nb. Large age missing in 2003 due to user input design 
error on internet version]
N 12 230 16 309
mean 33.01 33.73
standard deviation 11.45 11.82
median 31.0 32.0
range 14-90 14-89
missing n 2321 123
Ethnicity * White British 84.0
12177/14498
81.2
13252/16311
White other 10.4
1506/14498
11.4
1867/16311
Asian 2.0
294/14498
2.9
465/16311
Black 1.6
239/14498
2.3
379/16311
All other groups 1.9
282/14498
2.1
348/16311
missing n 53 121
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UK sample description 
* = p<.01 (chi-squared) difference across the two years
2003 2005
total sample size 14551 16432
Income * <5k 10.8
1542/14311
10.4
1669/16104
£5k – £14k 25.4
3633/14311
22.8
3668/16104
£15k – 24k 29.0
4157/14311
27.7
4461/16104
£25k – £34k 17.8
2546/14311
18.9
3040/16104
£35k+ 17.0
2433/14311
20.3
3266/16104
missing n 240 328
HIV testing history (ns) Never 44.1
6377/14468
43.5
7056/16218
Last negative 49.6
7180/14468
49.9
8100/16218
Positive 6.3
911/14468
6.5
1062/16218
missing n 83 214
Current (male) relationship status * Single 47.4
6758/14253
45.6
7379/16167
Partnered 52.6
7495/14253
54.4
8788/16167
missing n 298 265
Any female sexual partners in the last year * No 89.3
12989/14551
86.7
14249/16431
Yes 10.7
1562/14551
13.3
2182/16431
missing n 0 0
Number of male sexual partners in the last year * none 6.2
880/14215
7.0
1135/16255
one 17.9
2538/14215
19.0
3088/16255
2, 3 or 4 28.1
3992/14215
27.6
4487/16255
5 to 12 23.6
3352/14215
22.9
3730/16255
13 to 29 13.0
1842/14215
12.5
2027/16255
30+ 11.3
1611/14215
11.0
1788/16255
missing n 336 177
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2.3 POTENTIAL ACCEPTABILITY OF PEP
Before turning to the measures of awareness and uptake of PEP, we look brieﬂy at its potential 
acceptability. In GMSS 2003, 97.4% (12862/13210) of respondents said they would consider taking 
PEP if they thought they had been sexually exposed to HIV. In 2005 this ﬁgure dropped to 95.9% 
(14172/14773). Adjusting for demographic diﬀerences in the samples, the odds ratio of saying yes 
in 2005 was 0.71 (95% conﬁdence interval (CI), 0.60–0.83). This suggests a drop in the apparent 
acceptability of PEP. The educational campaign stressed the potential negative impact of taking PEP 
(eg. “It can cause severe side eﬀects such as diarrhoea, nausea and prolonged headaches”), and this 
ﬁnding may reﬂect an increase in knowledge about this aspect of the intervention. However, the 
vast majority of Gay and Bisexual men would still consider PEP if they thought they needed it.
2.4 CHANGES IN AWARENESS OF PEP
Across the UK as a whole, in 2005 men were 2.4 times more likely to be aware of PEP than they were in 
2003, an increase from 22.2% to 38.5%. Awareness of PEP signiﬁcantly increased in every demographic 
sub-group. The following graphs show the proportion of men who had heard of PEP in each year across 
each demographic group. Increases were highest among men living in the South of England, men with 
large numbers of male sexual partners, those over 50 years of age, and those who had tested for HIV.
In 2003, men recruited using the booklet were 1.4 times more likely to be aware of PEP than men 
recruited via the internet. Between 2003 and 2005 the increase in awareness was similar in internet 
and booklet recruited samples and so the same diﬀerence in awareness by recruitment method 
pertained in 2005.
2.4.1 Residence and changes in PEP awareness
In 2003 awareness of PEP was highest among men in London and Brighton & Hove. Compared to 
men in London, awareness was signiﬁcantly lower in all areas of the UK except Brighton and Hove. 
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Figure 2.4.1: Increased awareness of PEP by area of residence, 2003-2005 (ﬁgures for South England include Brighton & 
Hove, and for North England include Manchester. Figures for men living in these two authorities are also shown separately). 
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By 2005 there had been a signiﬁcant increase in awareness of PEP in all areas of the UK. The increase 
was greatest in London, South England and in particular Brighton & Hove. In 2005, a Gay man in 
Brighton & Hove was 3.4 times more likely to be aware of PEP than he was in 2003. The increase was 
most modest in Scotland which is outside the remit of the CHAPS programme. As a result of these 
changes, the diﬀerence in awareness of PEP between the South of England and the rest of the UK 
was greater in 2005 than it had been in 2003.
2.4.2 Age and changes in PEP awareness
In 2003, men under 20 were less 
likely to be aware of PEP than 
older age groups, awareness 
being highest among men in their 
30 and 40s. By 2005 awareness 
of PEP had increased in all age 
groups with the largest increase 
among men in their 40s and the 
over 50s. 
In 2005 men in their 30s and 40s 
were still most likely be aware of 
PEP and the diﬀerence between 
them and men under 20 had 
increased. 
Since men in the 30-50 age group 
are most likely to have knowingly 
engaged in sero-discordant UAI 
(see Reid et al. 2002, p.32), the 
need for PEP could be seen as highest here.
2.4.3 Ethnicity and changes in PEP awareness
In 2003 awareness of PEP was 
higher among the White other 
group relative to White British 
men. It was not signiﬁcantly 
diﬀerent across other ethnic 
groups. 
By 2005 awareness of PEP had 
increased in all ﬁve ethnic groups. 
The increase was most modest 
among Asian men who have 
previously been shown to be 
least likely to recognise mass 
media interventions targeted 
at Gay men. The result was the 
same ethnic group diﬀerence in 
awareness in 2005: men of White 
other ethnicities were most likely 
to be aware of PEP.
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Figure 2.4.2: Increased awareness of PEP across age groups, 2003 - 2005. 
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Figure 2.4.3: Increased awareness of PEP across ethnic groups, 2003 - 2005. 
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2.4.4 Income and changes in PEP awareness 
In 2003 awareness of PEP was 
incrementally higher with 
increasing income; men who had 
an income of over £35000 were 
2.0 times as likely to be aware 
of PEP than were men with an 
income of under £5000. 
By 2005 awareness of PEP had 
increased in all ﬁve income 
groups but with higher values 
for men with higher incomes. 
Consequently in 2005, men with 
an income of £35000 or more 
were 2.5 times more likely to be 
aware of PEP than those with an 
income of less than £5000. 
2.4.5 HIV testing history and changes in PEP awareness
In 2003 diagnosed positive men 
were 4.0 times more likely to be 
aware of PEP than those whose 
last test was negative, and were 
7.7 times more likely to be aware 
of PEP than those who had never 
tested. 
By 2005 awareness of PEP had 
increased in all three HIV testing 
history groups but the rise was 
signiﬁcantly greater among men 
who had tested (either positive or 
negative) for HIV than those who 
had never tested. Consequently 
in 2005, men who had tested 
positive were still 4.0 times more 
likely to be aware of PEP than 
men who had tested negative, 
but were now 10.0 times more 
likely to be aware of it than men who had never tested for HIV.
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Figure 2.4.5: Increased awareness of PEP by HIV testing history, 2003 - 2005. 
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Figure 2.4.4: Increased awareness of PEP across income groups, 2003 - 2005. 
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2.4.6 Female sex partners and changes in PEP awareness
In 2003 men who had sex with 
a woman in the preceding year 
were 0.7 times less likely to have 
heard of PEP than men who had 
no female sex partners. 
By 2005, awareness of PEP had 
increased among both men with 
and without a female sex partner 
in the last year but the increase 
was greater among men without 
a female sex partner. In 2005 
the diﬀerence in PEP awareness 
between these two groups was 
even greater: men with a female 
sex partner were now 0.4 times 
less likely to be aware of PEP as 
men without a female sex partner.
2.4.7 Number of male sex partners and changes in PEP awareness
In 2003 awareness of PEP 
was higher among men with 
increasing numbers of male sex 
partners in the last year. Men who 
had thirty or more partners were 
2.6 times more likely to be aware 
of PEP than men who had no 
male partners. 
Between 2003 and 2005 the 
increase in awareness of PEP was 
greatest among men with more 
male partners. Consequently in 
2005, the diﬀerence in awareness 
of PEP between men with few 
and those with many partners 
was greater than it had been in 
2003. Men who had thirty or more 
partners were 3.6 times more 
likely to be aware of PEP than 
men who had no male partners. 
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Figure 2.4.6: Increased awareness of PEP by having any female partners in 
the last year, 2003 - 2005. 
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Figure 2.4.7: Increased awareness of PEP by volume of male sexual 
partners in the last year, 2003 - 2005. 
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2.5 CHANGES IN PEP SEEKING
Across the UK as a whole, in 2005 men were 1.4 times more likely to have ever sought PEP than they 
were in 2003, an increase from 1.0% of all men to 1.4%. The small absolute number of men seeking 
PEP means we found fewer group diﬀerences that were statistically signiﬁcant but the proportion of 
men seeking PEP did not decline in any demographic sub-group. There were statistically signiﬁcant 
increases in PEP seeking among: men in their 30s; White British men; men with an income over 
£35,000; men whose last HIV test was negative; men who did not have a female sex partner; and 
men who had fewer than 13 male sex partners. The following graphs illustrate the signiﬁcant 
diﬀerences across each demographic group.
In 2003 ever having sought PEP was signiﬁcantly higher among men recruited using the booklet 
compared to those recruited using the internet. A greater increase in PEP seeking among men 
recruited on the internet meant this diﬀerence was not signiﬁcant in 2005.
2.5.1 Residence and changes in PEP seeking
In 2003, having sought PEP was signiﬁcantly more common among London residents compared to 
elsewhere in England and in Scotland. 
In 2005 the increase in PEP seeking was similar across all areas, so London still had a higher 
prevalence than elsewhere of men having ever sought PEP.
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Figure 2.5.1: Increases in PEP seeking by area of residence, 2003-2005 (ﬁgures for South England include Brighton & Hove, 
and for North England include Manchester. Figures for men living in these two authorities are also shown separately). 
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2.5.2 Age and changes in PEP seeking
In 2003 men in their 20s were most likely to have sought PEP. Following increases among all age 
groups, in 2005 there was no signiﬁcant diﬀerence across age.
2.5.3 Ethnicity and changes in PEP seeking
There were no signiﬁcant diﬀerences in having sought PEP by ethnic groups in either 2003 or 2005. 
2.5.4 Income and changes in PEP seeking
In 2003 there was no signiﬁcant 
diﬀerence in having sought PEP 
by income. By 2005 we found a 
greater increase in PEP seeking 
among men in the highest 
income group, so that men with 
an income of more than £35000 
were 2.5 times more likely to 
have sought PEP than those with 
an income of less than £5000. 
2.5.5 HIV testing history and changes in PEP seeking
In 2003 men who had tested HIV 
positive were more likely to have 
ever sought PEP than men who 
had never tested for HIV. 
By 2005 there had been a 
signiﬁcant increase in PEP 
seeking only among men whose 
last test was HIV negative so that 
in 2005 positive men were still 
more likely to have sought than 
never tested men.
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Figure 2.5.4: Increases in PEP seeking across income groups, 2003 - 2005. 
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Figure 2.5.5: Increases in PEP seeking by HIV testing history, 2003 - 2005. 
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2.5.6 Female sex partners and changes in PEP seeking
There were no signiﬁcant diﬀerences in having sought PEP by having or not having female sex 
partners in the last year either in 2003 or 2005. 
2.5.7  Number of male sex partners and changes in PEP seeking
In 2003, men with 13 or more 
male sexual partners in the last 
year were more likely to have 
sought PEP than those with 12 
or fewer. There was a greater 
increase in PEP seeking among 
men with fewer male partners. 
However, in 2005 men with larger 
numbers of partners were still 
more likely to have sought PEP.
2.6 CHANGES IN TAKING PEP
The following graphs show the proportion of men in each year and in each demographic sub-group 
who had ever taken PEP. The overall proportion of men who had ever taken PEP rose from 0.6% in 
2003 to 1.2% in 2005, with an adjusted odds ratio for having taken PEP of 1.93 (95% CI 1.43-2.61). In 
no demographic sub-group did the proportion who had taken PEP decline between 2003 and 2005.
In 2003 having taken PEP was signiﬁcantly more common in the booklet sample. The rise in having 
taken PEP was only signiﬁcant in the web sample, but in 2005 the booklet sample was still more 
likely to have ever taken PEP.
2.6.1 Residence and changes in taking PEP
In 2003 ever having taken PEP was signiﬁcantly less common in the rest of England than it was in 
London. There were signiﬁcant increases in having taken PEP in London, South England and North 
England. In 2005 having taken PEP was still higher in London than elsewhere with the exception of 
Brighton and Hove.
 
Ever tried to get PEP
4
3.5
3
2.5
2
1.5
1
0.5
0
%
 o
f s
ub
-s
am
pl
es
  2003   2005
Number of male sexual partners last year
none one
Figure 2.5.7: Increases in PEP seeking by volume of male sexual partners 
in the last year, 2003 - 2005. 
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2.6.2 Age and changes in taking PEP
There was no statistically signiﬁcant diﬀerence in PEP taking at diﬀerent ages in either year. From 
2003 to 2005 having taken PEP rose in all age groups, and the rise was signiﬁcant among men in 
their 30s.
2.6.3 Ethnicity and changes in taking PEP
The was no statistically signiﬁcant diﬀerence in PEP taking in diﬀerent ethnic groups in either year. 
From 2003 to 2005 having taken PEP rose in all ethnic groups and the rise was signiﬁcant among 
White British men and those in all other ethnic groups.
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Figure 2.6.1: Increases in PEP taking by area of residence, 2003-2005 (ﬁgures for South England include Brighton & Hove, 
and for North England include Manchester. Figures for men living in these two authorities are also shown separately). 
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2.6.4 Income and changes in taking PEP
Men with higher incomes were 
more likely to have taken PEP and 
this diﬀerence increased from 
2003 to 2005. The increase in 
PEP taking being greatest in the 
highest income bracket.
In 2005 men with an income of 
over £35000 were 2.6 times as 
likely to have taken PEP as those 
with an income of under £5000.
2.6.5 HIV testing history and changes in taking PEP
In 2003, men with diagnosed HIV 
were more likely to have taken 
PEP in the past than men whose 
last test was negative and those 
who had never tested. 
To 2005 the increase in having 
taken PEP was greatest among 
men whose last test was negative, 
but less pronounced among 
diagnosed positive men. In 2005 
men who had never tested were 
less likely to have taken PEP 
than were men who had tested, 
irrespective of the result.
Since all people who take PEP 
should have both pre- and 
post-PEP HIV tests, we should 
expect having taken PEP to rise 
most among men whose last HIV test was negative, as observed. However, that the proportion of 
men who had tested HIV positive that had ever taken PEP was similar to the proportion among 
men whose last test was negative needs accounting for. It is clear that some men who take PEP 
subsequently go on to sero-convert to HIV.
PEP is by deﬁnition needed by the group of men at highest risk of HIV infection. Since prescribing 
PEP alone meets few HIV prevention needs other than the immediate biological need, having 
been prescribed PEP does not automatically place men in at lower risk in the future. It is likely men 
who have taken PEP in the past are still at signiﬁcant risk from HIV and it should therefore not be 
surprising that some men go on to sero-convert to HIV.
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Figure 2.6.4: Increases in PEP taking across income groups, 2003 - 2005. 
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Figure 2.6.5: Increases in PEP taking by HIV testing history, 2003 - 2005. 
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2.6.6 Female sex partners and changes in taking PEP
In 2003 there was no statistically signiﬁcant diﬀerence in PEP taking among men who had a female 
sex partner and those who did not. However, men who did not have a female sex partner in the last 
year remain more likely to have taken PEP. 
2.6.7 Number of male sex partners and changes in taking PEP
In both years, men with higher 
numbers of partners were more 
likely to have taken PEP. In 2003 
men with 13 or more partners in 
the last year were 3.6 times more 
likely to have taken PEP than 
men with fewer than 13 partners. 
Having taken PEP rose in all 
groups between 2003 and 2005.
2.7 SUCCESSFUL PEP SEEKING
In 2003, 59.1% of all men that had ever sought PEP had ever taken it. There were no signiﬁcant 
diﬀerences across demographic groups in men’s rate of having taken PEP among those that had 
sought it. 
Overall, between 2003 and 2005 the proportion of men who had ever sought PEP who had ever 
taken it rose signiﬁcantly, from 59.1% to 73.9% (X2=9.572, df=1, p<.01), suggesting an increase in 
access to PEP among those seeking it. Again demographic diﬀerences in taking PEP among those 
that had sought it were not the norm but there were two signiﬁcant results. Among men that 
had ever sought PEP in 2005, those living in London (81.9%, n=99/121) or Wales (85.7%, n=6/7) 
were signiﬁcantly more likely to have ever taken it than men living elsewhere. Also in 2005 men 
with higher incomes who had ever sought PEP were more likely to take have ever taken it: 63.3% 
(n=38/60) of those with an income of under £15000 who had sought PEP had taken it compared 
with 77.0% (n=144/187) of those with an income over £15000 (X2=4.379, df=1, p<.05).
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Figure 2.6.7: Increases in PEP taking by volume of male sexual partners in 
the last year, 2003 - 2005. 
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2.8 SUMMARY
In GMSS 2003, 97.4% of men said they would consider taking PEP if they thought they had been 
sexually exposed to HIV. In 2005 this ﬁgure dropped to 95.9%. This suggests a small drop in the 
apparent acceptability of PEP as an intervention. However, the vast majority of Gay and Bisexual 
men would still consider PEP if they thought they needed it.
In 2005, across the UK as a whole, men were 2.4 times more likely to be aware of PEP than they 
were in 2003, an increase from 22.2% to 38.5% among all men. While awareness of PEP signiﬁcantly 
increased in every demographic sub-group, the increases were not uniform. They were most 
pronounced among men living in the South of England, men with large numbers of male sexual 
partners, those over 50 years of age, and those who had tested for HIV. The changes in awareness 
between 2003 and 2005 maintained diﬀerences across ethnic groups (with the White other group 
being most aware). They increased diﬀerences across area of residence (London and the South 
being most aware); age (men in their 30s and 40s being most aware); income (men with higher 
incomes being most aware); HIV testing history (positive men being most aware); gender of partners 
(exclusively homosexually active men being more aware); and number of male partners (men with 
more male partners being more aware).
While these disparities were usually in the direction of demographic sub-groups that are most 
likely to be involved in HIV exposure (London residents, men in their 30s, men with larger numbers 
of male partners) some were not. Until such time as awareness of the existence of PEP is universal 
it should also be most common among Black men and men with lower incomes (and hence less 
education). 
Similarly ever having sought PEP rose from 1.0% of all men to 1.4% between 2003 and 2005. 
The small absolute number who had ever sought PEP meant fewer group diﬀerences that were 
statistically signiﬁcant but the proportion of men who had sought PEP did not decline in any sub-
group. There were statistically signiﬁcant increases in PEP seeking among: men in their 30s; White 
British men; men with an income over £35,000; men whose last HIV test was negative; men who did 
not have a female sex partner; and men who had fewer than 13 male sex partners.
In order to seek out PEP men must be aware of its existence but they also must have the conﬁdence 
and skills to present for it. The changes in PEP seeking between 2003 and 2005 eliminated 
diﬀerences across age and maintained diﬀerences across: residence (being most common in 
London); HIV testing history (men who had tested being most likely to seek it); relationship status 
(men in relationships being more likely to seek); and number of male sexual partners (men with 
higher numbers of partners being more likely). It also created diﬀerences across income, with men 
with higher income now being more likely to seek PEP. 
The overall proportion of men who had ever taken PEP rose from 0.6% in 2003 to 1.2% in 2005. 
In no demographic sub-group did the proportion who had taken PEP decline between 2003 and 
2005. Overall, between 2003 and 2005 the proportion of men who had ever sought PEP who had 
ever taken it, rose from 59.1% to 73.9%, suggesting an increase in access to PEP among those 
men seeking it. Again demographic diﬀerences in getting PEP when it had been sought were not 
the norm but there were two signiﬁcant results. Among men seeking PEP in 2005, those living in 
London and Wales were signiﬁcantly more likely to have taken it than men living elsewhere. Also 
men with higher incomes who sought PEP were more likely to have taken it than men with lower 
incomes. 
The recurrent problem of income (acting as a surrogate marker for education and class) is a major 
one to which we return in some detail in Chapter 4.
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Seeking & getting PEP
 
3.1 METHODS AND SAMPLE 
In this chapter, we describe in detail the experiences of thirty Gay men and Bisexual men who tried 
to access PEP following potential sexual exposure to HIV. 
3.1.1 Methods
In 2005 men completing the online version of the Gay Men’s Sex Survey who said they had ever tried 
to get PEP were invited to take part in a 30 minute telephone interview about their experiences. 
Telephone interviewing enabled men from a range of geographical locations to be interviewed at a 
time and place that suited them. Initial screening ensured that only those who had attempted to access 
PEP in the UK following a sexual (rather than occupational) exposure took part. Interviewing took place 
between August and December 2005. The interviews were undertaken by two researchers and were 
audio tape-recorded with consent. Detailed annotations were made of the recordings which were used 
for analytical coding (in the case of close-ended questions) and reﬂective thematic analysis (in the case 
of open ended responses). Analysis was conducted by two researchers working independently.
At interview, men were asked to describe their knowledge and awareness of PEP prior to the most 
recent time they sought help in relation to a potential sexual exposure incident, their experiences of 
seeking advice or information about accessing PEP and what happened when they tried to access 
PEP. Men were also asked about their satisfaction with the clinical process, who else they had told 
about their experience, and what aﬀect they thought it had on future HIV-related risk. Those who 
were prescribed PEP were asked about follow-up care and side eﬀects. Men who had tried to access 
PEP more than once were asked about their most recent experience ﬁrst, and then asked for a brief 
account of the previous occasions when they had attempted to access PEP. 
3.1.2 Sample
The majority of the men were in their 20s and 30s at the time of interview (the mean age was 32 
and the range was from 18 to 48). Seventeen men were London residents, and the remainder lived 
in urban and non-urban settings in England (North West, Midlands, South West and South East) and 
Wales. Almost all men identiﬁed as White and most were British, though a quarter (n=7) were originally 
from North America, Australia or South Africa. One man was of unspeciﬁed mixed ethnicity. Most men 
(n=28) had remained in education after the age of 16 (the majority of these having done so for more 
than three years). The men were medium to high earners (two thirds earned more than £25000 a year, 
with over one quarter earning £40000 or more). The ethnicity, educational and income proﬁles of this 
sample are similar to the GMSS 2005 survey participants (see chapter 2) who had tried to access PEP. 
Both this and the GMSS sample of men requesting PEP tended to be White with higher educational 
qualiﬁcations and incomes. Knowing about and actively seeking health interventions involves a 
range of personal, social and cultural characteristics which are often concentrated within White 
middle-class cultures (Wilkinson 1986, Kawachi et al. 1997, Hawe & Shiell 2000) . Our samples 
therefore reﬂect a typical demographic proﬁle of early adopters of new health technologies.
Where quotes from respondents are used in this chapter, they are contextualised by three pieces 
of information about the speaker. The age of the respondent is given, as well as the type of clinic 
where they sought help (A&E or GUM) and their area of residence at the time of the incident (which 
in some cases is not the same as the area where they sought PEP). These areas have been classiﬁed 
using the Standard Regions for England (North, South, Midlands & Eastern, London) and Wales.
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3.1.3 When the potential risk incidents occurred
The table below describes when the possible exposure incident described in the interview occurred 
and the numbers of men for whom PEP was prescribed. We did not put a time limit on the recency 
of the potential exposure incident described in the interview. 
Exposure incident Number of respondents
within six months of interview 14 (of which 8 were prescribed PEP)
between 6 and 18 months prior to interview 10 (of which 8 were prescribed PEP)
between 18 months to 3 years prior to interview 2 (both were prescribed PEP)
more than three years prior to interview 4 (all of whom were prescribed PEP) 
The majority of respondents (n=24) described a sexual risk incident that had occurred in the 18 months 
prior to interview, with nearly half (n=14) in the six months prior to interview. Of the twenty-four men 
describing an incident in the eighteen months prior to interview, sixteen were prescribed PEP. Of the six 
men who described receiving PEP more than 18 months prior to interview, all were given PEP. 
In the remainder of this chapter, we ﬁrst describe how men found out about PEP and how they 
realised they might need to take it. We move on to describe their experiences of presenting to 
clinics and the ways in which PEP was prescribed. We then describe taking PEP both in terms of 
physical symptoms and side eﬀects and the broader impact on personal, social and sexual lives.
3.2 KNOWING ABOUT PEP, NEEDING PEP 
In this section, we explore how and where the men derived their knowledge about PEP generally, 
what speciﬁc events or triggers made them decide that they may need to take PEP and how they 
went about seeking help.
3.2.1  Knowledge about PEP
The following table describes when men in the sample had ﬁrst heard about PEP.
Heard of PEP ... No. of men
in the 18 months prior to interview 16
between one and a half years and three years prior to interview 5
more than three years prior to interview 9
Of the sixteen men who had learned of PEP in the 18 months prior to interview, ﬁve had only heard 
of it after the risk incident described at interview. In some of these cases, friends and sexual partners 
told them about PEP. One man described an encounter where he did not understand his casual 
partner’s attempt to disclose his HIV infection during unprotected sex. When their sero-discordancy 
became apparent, his partner told him about PEP. Others were told by the health professionals who 
they turned to for help following the exposure incident. Therefore, a signiﬁcant minority did not 
know what PEP was or how it might have helped them at the point when they ﬁrst realised they 
might have been at risk of HIV exposure. 
The remaining eleven men who became aware of PEP in the 18 months prior to interview said 
they had heard of it through the Gay press, health promotion interventions, friends and health 
professionals. 
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When you read the press there was a lot of informative stuﬀ about PEP at the time. I tend 
to look out for those things. There were three or four things, I think each of the major 
magazines had articles about it. The [CHAPS ﬁre extinguisher] poster was one of the ﬁrst 
things that informed me that PEP existed. 
45 years old, GUM, London
Without prompting, three men recalled the CHAPS campaign about PEP, launched in the national 
Gay press as well as targeted local press in London and Brighton in April 2004.
The ﬁve men who had heard about PEP between 18 months and three years prior to interview also 
recalled Gay press coverage and health promotion materials (in the UK and/or other countries). Of 
these, two mentioned the CHAPS campaign unprompted and one said that he had discussed PEP with 
a health professional at some point in the past, but that the campaign had revitalised his awareness.
In the main, the nine men who had known about PEP for three or more years were health professionals 
or had volunteered in the HIV sector or had a long-term partner with HIV. One described being told 
about PEP by an HIV positive casual sexual partner after an exposure incident occurred. A total of ﬁve 
men knew about PEP because they had tried to access it on at least one previous occasion. 
Knowledge about PEP was gained either at the point of need (after possible exposure), or through 
press advertising or through personal or professional networks. However, the decision to take action 
and seek help was not universally driven by prior knowledge of PEP. As we have said, some men 
were not aware of PEP until they sought advice in relation to a speciﬁc risk incident. For this reason, 
terminology such as ‘seeking’ PEP is not applicable to all men’s experiences (as not all men were 
actively ‘seeking’ it). 
3.2.2 Needing PEP
About a third of all respondents (n=9) said that they began considering PEP when they realised 
that a potential HIV exposure had occurred; either through condom failure or unplanned risk with a 
partner who was known or thought to have HIV. For these men, concern about the exposure event 
mobilised their prior knowledge and understanding of PEP. For instance, following a condom failure 
with his HIV positive partner, one man described how his concerns about the partner’s high viral 
load contributed to his desire to get PEP. 
My partner was only recently diagnosed, just after I met him. That was why I wanted to get 
PEP straight away, because I realised he would be highly infectious.
37 years old, GUM, London
Men tended to consider PEP when sexual incidents fell outside of the parameters they normally 
considered ‘safe’. This occurred in cases where a partner’s positive HIV status was known and where 
it was unknown. Where it was known, condom failure was often the trigger though one man 
considered PEP when he noticed his partner’s precum on his own broken skin while also knowing 
that the partner’s viral load was likely to be high. Where incidents occurred within relationships, 
sometimes men had to manage their positive partners’ feelings about the process, and in some 
cases this meant time taken for discussion rather than seeking PEP immediately after sex.
In cases where a partner’s HIV status was unknown, triggers often related to concerns about 
exposure to potentially infectious bodily ﬂuids including ejaculate (usually, but not always in 
relation to condom failure) and blood. One man described his reaction to an incident of receptive 
oral sex in a London cruising area.
I have never swallowed spunk or anything, I have never taken it in my body. And that was the 
ﬁrst time it had actually entered by body, in my eye. On that basis I felt it was signiﬁcant. I 
started thinking about PEP within the hour. I think there is a higher risk than normal, because 
of where I was. 
35 years old, GUM, London
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Again we note the signiﬁcance of men’s own boundaries of ‘safety’ being breached in these PEP 
narratives. It was the recognition of circumstances that men deﬁned as being outside of their 
comfort zone which tended to prompt action. 
Roughly another third (n=11) became aware that their partner was HIV positive following sexual 
contact, either through disclosure from the partner (n=9) or from rumours (n=2). Disclosure from 
partners often followed condom failure and some men said that their partners had disclosed in 
order to encourage them to seek out PEP. Disclosure also occurred when regular partners received 
an HIV diagnosis within the days following a sexual exposure incident. In the following example, 
disclosure emerged after a condom failure in the ﬁrst weeks of a new relationship.
He didn’t say anything at ﬁrst. I was saying, ‘These things happen’ and because he couldn’t 
look at me, I realised he was really horriﬁed. I worked it out very quickly myself by reading his 
reaction.
34 years old, GUM, Midlands & Eastern
Two men described ‘ﬁnding out’ about a casual sexual partner’s HIV status from third parties as 
the trigger for their concern about exposure to HIV. One man who said that he had been drugged 
by a sexual partner was told by friends the next day that the same man had been known to have 
infected others. Another said that he was telling a friend about a sexual encounter with a particular 
individual, when the friend said: “Did you know he was HIV positive?”. Although third party sources 
cannot be absolutely reliable, these respondents reacted to the revelations as though their sexual 
contacts’ HIV positive status was a certainty. 
For many (but not all) men, disclosure was the key event that compelled them to engage with the 
realities of the risk of exposure. Often, the sexual activity on its own was not suﬃcient to trigger 
a PEP-seeking response. Therefore additional information about a partner’s HIV status often 
intensiﬁed concerns about risk of exposure.
The ﬁnal group (roughly one-third) described some delay before considering PEP. In almost all of 
these cases, triggers such as condom failure or disclosure were absent. Instead, they spent some 
time alone or with friends reﬂecting on the sex they had before realising they may have been at risk. 
Often they described passionate, unrestrained, casual sex that they had enjoyed at the time, but 
which they later reﬂected upon with feelings of regret. 
The revelation of, ‘Oh my god, I’ve had unsafe sex with somebody I don’t know. How 
ridiculous, how stupid!’
34 years old, GUM, London
Often, within the interview, the risk incident was described as a unique behaviour – not something 
they would normally do. 
I went for a fumble in the park, if you like, and I don’t know what happened. And I was sort of 
being the active partner which was really bizarre.
39 years old, A&E, London
A dawning discomfort and a growing concern that their partner may have been positive often 
motivated them to talk to friends and get advice from professionals. Again a consistent element 
in these accounts was men’s identiﬁcation of an ‘exceptional’ occurrence that led them to be 
concerned about the risk of exposure. Whether their concern arose immediately or on reﬂection; 
whether it concerned the sexual activity or the sexual partner – these were individuals, who, in the 
main, took a great degree of care to protect themselves from the risk of exposure to HIV. Therefore, 
once they had identiﬁed the sexual incident as ‘out of the ordinary’ because it might have carried 
risk, they were motivated to act. The ﬁnding that men who access PEP are seeking to reassert 
equilibrium following a temporary loss of control regarding HIV exposure risk, is supported by 
similar research undertaken in Australia (Körner et al. 2003, 2005). 
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3.2.3 Delaying seeking PEP
In some cases one or two days passed before a respondent attempted to access PEP or seek help. A 
range of other priorities could delay a telephone call or a visit to a clinic. A few men did not feel that 
they were at risk of exposure until they were made aware of a sexual contact’s HIV status some time 
later – either from the sexual partner himself, through third parties, or in one case, after reading an 
updated positive proﬁle on Gaydar. Four men had sex while away from home, and travelled back to 
their home city or town before accessing a clinic. A small number went to work for the day and then 
set about accessing PEP after work, while others waited until the eﬀects of drink or drugs wore oﬀ 
ﬁrst. 
Despite some delays among a proportion of men, of the twenty-two men who were prescribed PEP, 
sixteen (two thirds) received their ﬁrst dose within 24 hours of the exposure incident. Of these, ﬁve 
men received PEP within six hours or less. All ﬁve of these men accessed GU clinics and Accident and 
Emergency Departments in London, and their decision to seek PEP promptly played as much of a 
role in the speed of their access as the promptness with which they were subsequently processed in 
the clinical environment. 
3.2.4 Seeking information: contacting a helpline
Most respondents went straight to an A&E, GUM or HIV clinic once they realised they needed help in 
connection with the risk incident. However, eight respondents contacted a helpline before seeking 
PEP. For all but one, this was their ﬁrst time attempting to access PEP and they were looking either to 
conﬁrm the existence of PEP, to ﬁnd out about time limits and eﬃcacy, or to ﬁnd out where to go to 
access it.
Of these, three called NHS Direct. In all three cases, operators had not been aware of the existence of 
PEP (despite all three events occurring after the release of the draft BASHH guidelines). The ﬁrst man 
called NHS Direct to ask about the recommended time-frame for receiving treatment, and was told 
to wait for a call-back, which came thirty minutes later.
I felt she shouldn’t have had to go and talk to someone when the question was over timing. I 
did kind of think they should know the answers to that. It did seem a like a bit of a like, ‘Oh no 
one ever asked that before’. 
43 years old, A&E, North
It was suggested to another respondent that he should go to GUM the next day. The third man was 
told that PEP was not available on the NHS, and no further advice was oﬀered.
The four respondents who contacted THT Direct with queries relating to PEP and the likelihood of 
exposure were satisﬁed with the expertise and support oﬀered. 
The THT helpline was very supportive of my emotional anxiety. They explained it in more 
depth. They might have mentioned a 24 hour time limit. He [the THT Direct operator] knew 
what he was talking about. His only doubt was whether it was a guarantee that you would 
always get PEP at A&E. I suppose it’s very expensive.
39 years old, A&E, London
This misgiving about access may have been justiﬁed in view of some men’s subsequent experience 
in clinics (see section 3.3 below).
One man contacted the National AIDS Helpline. He was unhappy with the advice that there was a 
very low risk of transmission if a sexual partner’s cum had got into his eye, when the HIV status of 
the partner was unknown.
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3.3 PRESENTING AT THE CLINIC
About half of the men acted on their concern about exposure by presenting at or telephoning A&E 
(n=14), and a similar proportion went directly to a GUM clinic (n=15). One individual went to see his 
GP ﬁrst, but was referred to GUM that same day. 
Twenty of the 30 clinical sites where men accessed help following sexual exposure incidents were in 
Greater London, although not all of these men were resident in London at the time. The remaining 
10 locations tended to be close to where respondents lived at the time. 
3.3.1 The initial clinical experience: deﬂected, referred, determined
Six men described being sent (or sending themselves) on from their ﬁrst clinical access point. In 
some cases, such events entailed appropriate professional referrals to expert clinical units, while 
in others, individuals were forced to become self-advocates in the face of denial, hostility and 
ignorance on the part of clinical staﬀ. The circumstances relating to each of these experiences are 
outlined below. 
Deﬂected
• One individual rang an A&E department at his local non-urban hospital in the Midlands. He was 
told to go to a GUM in a few days, which is where he was ultimately prescribed PEP. This occurred 
approximately two years prior to the interview.
• One man was told by an A&E nurse in a city in the North West that he should talk to someone at a 
Brook Advisory Centre. He went there, but as it was a Sunday, Brook was closed and he returned 
to A&E. He was not given PEP despite reporting receptive UAI with a partner of unknown HIV 
status because no one at the A&E knew what PEP was. This occurred six months prior to the 
interview.
Referred
• One man living in the South East (not London) went to see his GP after a risk incident. The GP told 
him about PEP and arranged an appointment at GUM that afternoon, where he was prescribed PEP. 
• A few months before the interview, one man contacted the A&E department at his local hospital 
in a city in the South West. He was processed through A&E and then sent directly up to the 
specialist infectious disease ward where his sexual partner received HIV clinical care. There he 
underwent a risk assessment and was prescribed PEP.
Determined (second tries)
• Following potential exposure to blood while engaging in insertive UAI with a man of unknown 
HIV status, one respondent was told at a central London A&E department that the low threshold 
of exposure meant they would not recommend PEP. He left with little conﬁdence in their 
assessment. The next day he went to a major HIV treatment centre and was prescribed PEP. This 
occurred six months prior to interview.
• More than three years before the interview, one man attended an A&E department in London 
where clinical staﬀ had not heard of PEP. The respondent insisted that they consult with a 
specialist, so they rang someone from a diﬀerent hospital who advocated the administration of 
PEP. However, the pharmacy was closed, so the respondent was told to return the next day. When 
the respondent returned and presented his prescription, the pharmacist recognised that it had 
not been properly written, and referred the respondent on to the HIV ward in the same hospital, 
where he was immediately given a starter pack. The HIV consultant in that ward mentioned that 
he was on call the previous day and that the A&E department should have contacted him for a 
consultation at the time.
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3.3.2 BASHH guidelines vs real life
In this section we assess the appropriateness of clinical care received by the men in this sample by 
applying the British Association for Sexual Health and HIV (BASHH) guidelines for the administration of 
PEP following sexual exposure (PEPSE) published earlier this year (Fisher et al. 2006). These guidelines 
were not oﬃcially endorsed when the incidents described in interviews occurred, however, as 
described previously, the draft version had been available for consultation among clinicians since April 
2004 (a time-frame within which most of the men described their most recent attempt to access PEP). 
The ﬁrst three sections below provide a brief summary of the sexual exposure situations covered 
in the guidelines that would apply to men having sex with male partners (a high prevalence 
population) in the UK, and are presented separately according to treatment recommendation. The 
last section provides a summary of those scenarios outlined by respondents that were not covered 
in the guidelines. We have allocated all the accounts of risk supplied at interview to this structure. 
The middle column gives the number of men who ﬁt into each category and the right hand column 
shows how many men in each of these categories did and did not ultimately receive PEP. Where 
men were initially refused or had to be persistent in order to obtain treatment this is speciﬁed. 
BASHH: Situations where PEP is recommended. Number PEP given?
RECEPTIVE ANAL SEX with a partner who is  
DIAGNOSED HIV POSITIVE  
(ejaculation not specified)
9 7 yes
1 no at first clinic / yes at next
1 no
RECEPTIVE ANAL SEX with a partner of  
UNKNOWN HIV status  
(ejaculation not specified)
8 4 yes
1 initially given incorrect prescription (then corrected)
3 no
INSERTIVE ANAL SEX with a partner who is  
DIAGNOSED HIV POSITIVE
4 3 yes
1 no (he presented to the clinic 12 days after the exposure)
BASHH: Situations where prescription of PEP 
should be considered
Number PEP given?
INSERTIVE ANAL SEX with a partner 
of UNKNOWN HIV status
5 3 yes
1 no at first clinic / yes at next
1 no
FELLATIO WITH EJACULATION with a partner who is 
DIAGNOSED HIV POSITIVE  
(modality not specified)
0 no respondents
FELLATIO WITH EJACULATION with a partner of 
UNKNOWN HIV STATUS  
(modality not specified)
0 no respondents
SPLASH OF SEMEN INTO EYE with a partner who is 
DIAGNOSED HIV POSITIVE
0 no respondents
Situations where prescription of PEP is not 
recommended
Number PEP given?
FELLATIO WITHOUT EJACULATION with a partner who is 
DIAGNOSED HIV POSITIVE
(modality not specified)
1 1 no
Situations described by respondents that are not 
addressed in current guidelines
Number PEP given?
SPLASH OF SEMEN INTO EYE with a partner of unknown 
HIV STATUS
1 1 no
PRE-CUM from a partner who is DIAGNOSED HIV 
POSITIVE ON BROKEN SKIN
1 1 yes
BLOOD from a partner who is DIAGNOSED HIV POSITIVE 
IN MOUTH
1 1 yes
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Of the 21 men who reported sexual exposure incidents for which current BASHH guidelines 
recommend administration of PEP, 16 received it. That means that ﬁve men who should have 
received PEP did not. 
Of the 5 men who reported risk exposure incidents for which UK clinical guidelines recommend 
that PEP should be considered, 3 received it, 1 was assessed as a lower risk, 1 was not adequately 
assessed as emergency clinical staﬀ were not aware of PEP. 
Regardless of the post-hoc nature of this analysis (in that the formal publication of the guidelines 
occurred subsequent to data collection), all of these inappropriate refusals took place within 18 
months prior to interview, and therefore followed the release of the BASHH draft guidelines and the 
CHAPS PEP awareness campaign. However, three quarters of men who should have been prescribed 
PEP did receive the medication in accordance with the guidelines.
There are important lessons to be learned from a closer examination of the ﬁve cases of 
inappropriate refusal. For this reason they are summarised below as a series of case studies.
Case #1: Person “A”
“A” had unprotected insertive and receptive anal intercourse with a casual partner of unknown HIV 
status during his ﬁrst ever sauna experience. When he presented to his closest A&E department in 
a large city in the North West, he was told by a triage nurse that PEP did not exist. It did not appear 
that any doctor was consulted during his visit. “A” had ﬁrst heard of PEP just one week earlier, when 
he was accessing GU services at that same hospital, and was very frustrated that his access was 
blocked, given that the health advisor who had told him about it had said to go to A&E if he thought 
he ever needed it. At the time of his last HIV test (two months after the incident) he was HIV negative.
21 years old, A&E, North
Case #2: Person “B”
“B” received news that his regular partner had just been diagnosed with HIV when he was away from 
home. He had recently had sex with him. With the support of someone he knew, he decided to get 
to the nearest A&E department in the city that he happened to be visiting. The A&E nurse had not 
heard of PEP, and she checked with the hospital pharmacist who had also not heard of it. No doctor 
was consulted. The nurse told “B” that it probably wouldn’t be of use anyhow, as he would have been 
exposed to his partner’s HIV over a long period of time, and the nurse recommended that he test for 
HIV at a GUM as soon as he could. 
“B” did not access the GUM clinic in that town at the time because it was out of hours, but when he 
returned home a few days later, he attended his local GUM for a test, as he and his partner were both 
registered there. Given that the window period for accessing PEP had expired by that point, it was 
not dispensed. The Health Advisor was knowledgeable about PEP, and informed “B” that only one 
of the two doctors at that clinic tended to dispense PEP, explaining that it was “just the way they 
practice medicine really”. At that visit, “B” had an HIV test, and the result was negative. One month 
later “B” tested positive for HIV. 
21 years old, A&E, Midlands & Eastern
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Case #3: Person “C”
“C” was at a sauna after taking recreational drugs. He felt that his perceptions had been signiﬁcantly 
altered and his judgement impaired by the drugs he had taken. He had receptive unprotected anal 
intercourse with at least six men, some of whom ejaculated inside him. 
When he presented at A&E as he was coming down oﬀ his high, he was persuaded by clinical staﬀ 
that the likelihood of sero-conversion was probably about 5%. “C” felt pressured to decide that 
the risks associated with PEP side eﬀects outweighed the likelihood of sero-conversion, and that 
because the incident had happened 52 hours before he arrived, that the treatment would possibly 
be ineﬀective. “C” left the hospital without PEP and deeply regretted the entire experience, as he felt 
he had been persuaded to make the wrong decision. 
29 years old, A&E, London
Case #4 Person “D”
“D” had sex with a man of unknown HIV status that he had sex with on a number of previous 
occasions. In this encounter, he engaged in receptive and insertive oral intercourse, protected 
receptive anal intercourse and unprotected insertive anal intercourse. Afterwards, he felt that he had 
been stupid for not having used a condom – he had never done that before. 
I had a dawning realization a couple of hours afterwards, of...you stupid boy, you shouldn’t 
have done that, and how daft I was, and then thinking, bollocks, that wasn’t a good idea, and I 
had heard of PEP and I thought I would access it.
“D” called NHS Direct but they were not aware of PEP and told him to get in contact with GUM 
the following day. He rang the GUM clinic at the nearest town the next day and spoke to a Health 
Advisor. After explaining the situation, the Health Advisor apparently said (in “D’s” words):
‘...well, if such a thing existed we would have people queueing out the door for it. It is available 
for staﬀ, so it isn’t just available for people to turn up and have!’
“D” challenged the Health Advisor with information that he had read about PEP on the internet, but 
this was dismissed. He did not approach any other services until three months later when he went to 
a diﬀerent GUM clinic for an HIV test because of his continuing concern about that incident. His most 
recent test was HIV negative.
32 years old, GUM, Midlands & Eastern
Case #5: Person “E”
“E” was having sex that included protected receptive anal intercourse with a casual partner. On 
more than one occasion the partner took the condom oﬀ and continued anal intercourse. “E” 
noticed and insisted that the partner put a condom on again, which he did, only for it to be taken 
oﬀ subsequently. “E” later calculated that he may have been exposed to unprotected sex for a total 
of 15 seconds throughout the encounter. The partner had told “E” he was HIV negative, but after the 
repeated condom removals, “E” did not trust the information the sexual partner had oﬀered him. “E” 
presented at A&E in a city in the North West. He was told the risk of exposure was low, and that PEP 
was not necessary. “E” left the hospital feeling reassured, but later felt that they had been dismissive 
of his concerns and he regretted not having been prescribed PEP.
Their reasoning was, it can make you quite ill, and they only give it to, sort of, rape victims, or 
people who know they’ve had exposure to HIV. They said because I didn’t know if he was HIV 
positive, they just refused to give it to me.
The incident took place just a month prior to interview, and “E” was going to wait two more months 
to take an HIV test.
20 years old, A&E, North
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3.3.3 Appropriate refusals
In three other cases where PEP was not prescribed, it was clear that the appropriate clinical decision 
was made. For two men, the risk of exposure was too low to consider administering PEP. One had 
engaged in receptive and insertive unprotected oral sex with an HIV positive partner, but because 
the partner had not ejaculated, the risk was considered negligible. The other reported a splash of 
semen in his eye from a partner of unknown HIV status, and again this was judged to be low risk. 
The last of these three men was refused PEP because he was outside the recommended time-frame 
for administration of the medication. This respondent had been informed of his sexual partner’s HIV 
positive status nearly two weeks following this exposure, which is when he tried to access help.
3.3.4 Warnings about side eﬀects
The majority of those who were prescribed PEP recalled being warned about the common side 
eﬀects of the medications that they were going to take. Most (19 of 22) were advised that they might 
experience diarrhoea and nausea while taking the medication, while about half were also advised 
that vomiting could result, and that they might experience fatigue during the treatment. Less than a 
quarter remembered any mention of potential liver damage before starting the medication, and only a 
few were advised about the possibility of skin rashes, hallucinations or dizziness. 
In those situations where clinical staﬀ took a signiﬁcant amount of time to explain dosing and side 
eﬀects on the ﬁrst clinical visit, men expressed satisfaction with the experience. 
I was quite pleased, because [the doctor] did sort of sit with me for about three quarters of 
an hour, or an hour going through everything with me.
29 years old, GUM, London
Although many also recalled discussions initiated by clinical staﬀ about the importance of adhering 
to the regime, less than half said that they had been given advice on how to minimise side eﬀects 
during their initial consultation. Some received a prescription on the same day for other medications 
to combat nausea and diarrhoea, and were told to take them as needed. Where it was oﬀered, 
advice on dealing with side eﬀects during the initial consultation was always conﬁned to the use of 
other medications rather than dietary or complementary interventions.
While a few men commented that all of the advance information on side eﬀects might dissuade 
those considering PEP, most felt that knowing all the possibilities in advance had consolidated their 
commitment to completing what could be an uncomfortable course of treatment.
I thought, hmm, not much fun, but slightly better than getting HIV. It’s worth it if it’s only for 
a month.
30 years old, GUM, London
Two men who had been on PEP previously mentioned that clinical staﬀ did not review side eﬀects 
in much detail because of their prior experience. Two others said that they did not feel safe in taking 
PEP before they started on the medication because of the lack of information about side eﬀects. In 
one instance, a man felt he had been “fobbed oﬀ” by an A&E doctor with the manufacturer’s highly 
medicalised drug leaﬂet.
He said, ‘Oh, if you need to know anything, there is a leaﬂet in there’. He said, ‘What do you do 
for a living?’. I said, ‘I am a teacher’. And he said, ‘Oh well, I presume you can read’. 
33 years old, A&E, London
Another said he had been too overwhelmed with information to adequately absorb anything 
during the initial consultation, and he would have appreciated literature to take home and read.
Half the men who were prescribed PEP were given written information about PEP at their initial 
consultation, and all of these had attended either GUM clinics, or London A&E departments 
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attached to hospitals with large HIV clinics. Most who had received such information said that they 
had beneﬁted from the opportunity to work through the materials at their own pace. One man who 
had not been oﬀered any such literature was surprised to ﬁnd out on the internet (once he was 
already on PEP) about the potential for organ damage due to the toxicity of the drugs he was taking. 
He was angry that the prescribing doctor had not made him aware of these issues.
3.3.5 Baseline HIV testing
Both the draft and published versions of the BASHH guidelines stipulate that a baseline HIV test 
result should be obtained as soon as possible in those cases where prescription of PEP is considered. 
It is mandatory that individuals for whom PEPSE is provided to undertake an HIV test (with 
rapid result) prior to, or shortly after initiating therapy.
Fisher et al. (2006: 87)
This HIV test is required to rule out the possibility that the individual is already HIV infected, as 
provision of PEP in those circumstance could aﬀect subsequent treatment options. Of the 22 
men who were prescribed PEP, only four were rapid-tested for HIV in the clinical setting where 
they presented. Twelve others had an HIV test administered at the time they presented, but test 
results were obtained over a time that ranged from three days to two weeks later. One further man 
remained disconcerted that the result of the HIV test that was taken at an A&E department was 
never communicated to him, as all of his follow-up was conducted at GUM. 
Five of the men who had taken PEP reported that no baseline HIV test was conducted at the time of their 
initial assessment, though two of these were tested the following day when they went to a specialist 
clinic. One other reported a delay of six days before the test was carried out. Two others said that an HIV 
test was not necessary at their initial assessment because they regularly tested (negative) for HIV. One 
respondent could not remember whether or not an HIV test was conducted or considered at all.
When respondents were asked to describe why they thought an HIV test might be considered at the 
time that they were presenting for PEP, most simply explained that it would be ineﬀective to take 
PEP if they were already HIV positive. However, a minority of men said that the reason for HIV testing 
at that stage had not been explained to them, nor had it always been absolutely clear at the point of 
drawing blood that an HIV test was going to be conducted on the sample.
3.3.6 Satisfaction with the initial assessment
We asked men to assess the degree to which they felt comfortable with the initial assessment of 
their case, and their satisfaction with the way their concerns were handled by healthcare staﬀ. 
Receiving PEP treatment was not automatically equated with clinical success or satisfaction. 
Thirteen of the 22 men who were prescribed PEP reported that they were generally satisﬁed with 
the clinical process. These men felt reassured by those with specialist knowledge, and with a 
supportive, reassuring manner.
They were good, they spoke to me really properly. They treated me with respect even though 
I didn’t feel like I deserved it. They were professional and they really knew what they were 
doing. It was really good. 
34 years old, A&E, Wales
Conﬁdence and satisfaction depended on individuals’ assessments of their healthcare professionals’ 
experience and expertise in dealing with PEP requests.
You put yourself into a good person’s hands, and they hold your hand, and they walk you 
through the process. And at the end they shake your hand and say ‘thank you very much, 
have a very good day’. That’s how I run my practice and that’s exactly how they ran me. 
45 years old, GUM, London
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Almost all of those who received PEP and were satisﬁed with their experience had accessed a 
GUM clinic in the ﬁrst instance. Those who expressed satisfaction with their experience in A&E 
departments had attended hospitals with large specialist HIV care units.
Nine men who received PEP were dissatisﬁed with some aspect of the process. The most common 
reason for feeling unhappy was the experience of ignorance and hostility from healthcare providers 
and administrative staﬀ. 
If you ring up for information, you get a ward sister. And a lot of [A&E] ward sisters are not 
really aware about PEP, especially after sexual exposure. That is what I tried to explain to this 
nurse and she got really pissed oﬀ with me, because I was trying to tell her that it is available 
and you have got to access it via this mechanism, but she wouldn’t have any of it. 
40 years old, A&E, Midlands & Eastern
Basically they could have made the [GU] receptionist a bit more aware of what is going on. 
They are the front-line and the ﬁrst people that anybody with an incident comes to see and 
if they don’t know the treatment is available, she really didn’t have a clue what I was talking 
about! I had to get stroppy and demand to see a doctor. 
39 years old, GUM, South
One respondent talked of the patronising attitude which his GU consultant displayed throughout 
the course of his treatment.
When I saw him last, I complained to him about having diarrhoea, my stomach was terrible 
with various other side eﬀects. And he looked at me, only through the corner of his eye, and 
he said: ‘Well you won’t be doing that again, will you’. 
48 years old, GUM, South
Some who presented to A&E were concerned that they were being treated by non-specialists who 
had little knowledge about HIV. 
He didn’t seem like he knew what he was doing, he had to keep going oﬀ and asking other 
people. If I had any questions he had to go and ask. It felt like he was kind of...I kind of got 
the impression that he would go and look it up in a book and then come back. 
18 years old, A&E, London
Others described being rushed through their consultation, leaving the hospital feeling ﬂooded with 
information and with no oﬀer of support. 
You know when someone gives you directions, they tell you really complex directions, and 
the minute you walk away, you think, what the fuck was that? I dunno what they said. It was 
kind of like that. 
33 years old, A&E, London
Not being prescribed PEP was not uniformly regarded as an unsatisfactory outcome. Three of the 
eight men who did not get PEP were satisﬁed with the overall experience because they felt that 
their concerns were met with professionalism, and it was clearly explained to them that their low 
risk of exposure did not justify administration of PEP. 
On a scale of one to ten I would actually give them ten.
Is that because you saw a specialist?
Of course, yeah. I just felt really comfortable, and really relaxed and everything he was saying 
– he was actually quite understanding. 
36 years old, GUM, South
All the men whose PEP refusals were clinically inappropriate (see section 3.3.2) were dissatisﬁed 
with their experience. As one said:
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To be honest I was quite annoyed after I came out, because they were quite dismissive. And 
basically told me to just not do it again, and there was basically nothing they could do. 
20 years old, A&E, North
Another reacted with anger against the professionals whom he felt were purposefully withholding 
treatment that could protect him from infection.
And I was just really, really upset. I felt that they were holding back PEP for ‘real’ emergencies. 
God knows what a real emergency is!
29 years old, A&E, London
One respondent reported feeling partly responsible for his disappointing experience because he 
had not been able to give the A&E staﬀ more concrete information about PEP and they had not 
heard of it. When asked if the staﬀ did anything to ﬁnd out about what treatment might have been 
available, he replied:
They might have done had I known it was called PEP and stuﬀ and they might have been 
able to go away and ﬁnd out what PEP is. 
21 years old, A&E, North
One man who had subsequently been diagnosed with HIV described having low expectations of 
being able to get PEP. While he described the experience as “somewhat disappointing”, he felt that 
this outcome was probably not unusual, and he didn’t blame the individuals involved.
I had already read about diﬃculties getting hold of PEP anyway, so I wasn’t necessarily 
expecting them to have heard of it or know of it... At the time I didn’t really think anything of 
it. I thought, ‘You know she’s tried, there isn’t a lot she can do’, and I still think that now really.
21 years old, A&E, Midlands & Eastern
Men’s satisfaction with their initial clinical experience was not necessarily outcome-based. Among 
those who described a satisfactory experience, what was valued above all else was the perception 
that their case was being assessed by someone with expert knowledge of HIV treatments, and they 
were treated with dignity and respect. When dissatisfaction was expressed, it was typically related to 
a sense that health providers’ homophobia, embarrassment or clinical ignorance had interfered with 
appropriate assessment and professional conduct. It was also evident that a small number of the 
men who were more ambivalent about their negative experiences felt that they should not expect 
any better from the NHS. Those who took this approach regarded their experience as a typical 
outcome of an over-burdened institution, in which non-specialists could not be expected to assess 
and treat every case appropriately.
3.4 TAKING PEP
3.4.1 Follow-up care
Among those men who did take PEP, their pathways of care were inﬂuenced by where they had ﬁrst 
been assessed. Those who had initially been seen at a GUM or HIV clinic were usually enrolled in a 
follow-up regime before they departed from that ﬁrst visit. There were also a few men who indicated 
that A&E staﬀ had made referrals for their ongoing care, making it clear that specialist care was a 
priority.
[It] was pretty much we’ll give you the starter pack and you need to go to [named GUM] to 
talk to a consultant. 
43 years old, A&E, North
The few A&E departments that provided clear guidance and referral pathways for respondents 
were located in hospitals with large specialist HIV clinics. Most individuals who attended A&E 
departments were given enough medication for a few days, and told to go to any GUM department 
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where medication for the entire course would be made available. Those without speciﬁc referrals 
(ie. booked appointments) were left to negotiate the overcrowded GUM system with no support. 
For instance, on the last day of his starter pack medication, one man attended the central London 
walk-in GUM service that was recommended by the A&E department. He was told he had arrived 
too late in the day for an appointment, and despite explaining the urgency of the situation with 
his medication, the receptionist sent him away. He crossed the city to another GUM that he had 
attended in the past, where he was provided with medication and follow-up care for the remainder 
of his treatment.
The clinical guidelines recommend that individuals presenting for PEP should be “referred and seen 
as early as possible by a clinician experienced in the management of anti-retroviral therapy” (Fisher 
et al. 2006: 87), regardless of whether PEP is oﬀered or accepted. Referral processes described by 
the men taking part in this study varied enormously. Of the eight men who did not take PEP, none 
were given direct referrals to specialist support or advice – a few were simply told to go to GUM in 
three months for an HIV test. Of the ten men whose initial PEP prescription was issued by an A&E 
department, only three had a clear recollection of attending specialist care the following day. The 
most common experience was to seek GUM or HIV specialist support when the medication in the 
starter pack was running low, as advised when they left A&E. In the main, the twelve men who had 
been prescribed PEP by a specialist GUM or HIV clinic had been given follow-up appointments a few 
days to a week after their ﬁrst visit. 
Once a part of the specialist GUM system, most men were reassured by the conﬁdence and expertise 
of the clinical and support staﬀ who managed their ongoing treatment. Several said how helpful it was 
to be able to access treatment and counselling specialists during their routine weekly appointments.
I was rather depressed to be on PEP, as you can imagine, and they do help you with your 
positive thinking, and to stay on track, you know?
26 years old, GUM, Wales
In addition to being able to access support relating to their treatment at scheduled appointments, 
more than a third of those on PEP were oﬀered more ﬂexible means of support. Some were able to 
telephone their health advisor and counsellors at any time. Those who took this up described calling 
about side eﬀects, missed doses, and general adherence support.
However, a third of the men who took PEP (n=8) described being oﬀered no emotional or adherence 
support while they were on treatment. While some did not ﬁnd this problematic, others felt that 
they had been left on their own by clinical staﬀ who demonstrated little concern for either their 
overall well-being or the treatment outcome.
If anything, that’s what kind of, I just felt was a bit of a let down with the whole thing, 
because I really felt that they were kind of lacking that ongoing support. There was no oﬀer 
of, give us a ring, or anything like that. I felt very much, kind of alone, really. 
34 years old, GUM, London
In the majority of cases, men described receiving prescriptions for only seven days’ of medication at 
a time. This system ensured that those on PEP would be seen by the clinic on a weekly basis while 
they were on treatment, for the purposes of monitoring side-eﬀects, taking bloods and checking 
on adherence and psychological issues. When men were given all of their medication at once, some 
reported not returning for follow-up care at all (due lack of interest, fear of needles, or discomfort 
with clinic attendance).
Most of those who attended follow-up care described undergoing systematic liver function testing, 
screening for other STIs and side-eﬀects monitoring. Four men had their medications changed 
while they were taking PEP (two because of severe side eﬀects, one because of new treatment 
information about the source, and one was told that he had been given ‘the old kind of PEP’ by the 
A&E department that he had originally attended).
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3.4.2 Experiences of side eﬀects
It is beyond the capacity of this study to oﬀer a comprehensive report of treatment regimes or 
associated side eﬀects. However, we make a brief comment on the ways that side eﬀects impacted 
on men’s lives. 
While only a quarter of the men who were prescribed PEP (n=6) could clearly remember the 
names of the medications they had taken (the remainder having no or uncertain recall), all could 
remember their side-eﬀects. Only three men reported no side eﬀects. The side eﬀects experienced 
by the remainder ranged in severity. Twelve reported a range of symptoms that typically included 
vomiting, nausea, diarrhoea and fatigue. A few of these felt seriously unwell while they remained on 
the medication. Some took time out from their responsibilities while others were unable to exercise 
or socialise much at all.
Those with persistent symptoms found the prescription of anti-nausea and anti-diarrhoea 
medication helpful. A few men received further clinical and counselling support in dealing with 
their side eﬀects when they returned to their clinic for subsequent visits. The two men who had their 
medications changed because of side eﬀects described fairly serious reactions (including a serious 
and painful rash, severe vomiting and hallucinations).
Some whose side eﬀects were mild to moderate felt that clinical staﬀ were perhaps over-
emphasising the potential impact of being on treatment. However, none of those who experienced 
side-eﬀects expressed any regret about their decision to take PEP. Most felt that the inconvenience 
had been worthwhile.
3.4.3 PEP adherence
All but one of the men prescribed PEP reported completing the full course of treatment. It is likely 
that this is a group who were highly motivated to complete their treatment. That is, as they had 
been proactive in seeking help and accessing PEP their reported completion rate should not 
surprise us.
Ten respondents reported imperfect adherence, but for most this consisted of one or two missed 
doses. Half of those who reported missed doses said that they had occurred toward the end of the 
treatment period. This was sometimes accompanied by a sense that it was less important to remain 
totally adherent in the latter stages of taking PEP. One man who had expressed his disappointment 
at the lack of adherence support said:
I actually stopped two days before I was due to complete because I was so ill, I thought I 
just couldn’t take them any more. I was like: ‘Ugh, I’m gonna die’. So I just stopped two days 
before I was going to ﬁnish I just stopped. And then I probably missed one or two during the 
course leading up to that, due to social kind of commitments.
34 years old, GUM, London
Another recognised that his mounting psychological turmoil about having to be on the medication 
was hampering his ability to take it on time, particularly in the latter stages.
In the beginning I was so paranoid about it I was anal about it. Towards the end, the last 
week and a half was diﬃcult, I was at the point, I was delayed in taking it because I would sit 
there for half and hour to an hour staring at the bottle thinking ‘I don’t want to take these 
things anymore!’
29 years old, A&E, London
It was clear that there was a relationship between side eﬀects and adherence, in that men who had 
fewer and less severe reactions to the medication found it easier to never miss doses. 
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3.5 SOCIAL, PERSONAL AND SEXUAL IMPACT OF PEP
We conclude with an examination of how taking PEP impacted on men’s personal and social life as 
well as their sexual decision making.
3.5.1 Telling others about PEP
Those who were prescribed PEP were highly selective about telling others that they took it. Among 
those who did not receive PEP, very few had told others about their experience, apart from the 
friends or partners whom they had asked for advice following the exposure incident itself. There 
were a range of reasons given by men for not discussing either seeking or taking PEP. 
For many, needing PEP was an indicator of having taken a risk, of having made a serious mistake. 
A number of men talked about how they had to confront their own sense of irresponsibility at the 
point when they realised they were in need of help. So it should not surprising that some preferred 
not to have to rehearse that sensation by later explaining to others that they had needed PEP. As 
one man said:
I have a lot of middle-aged friends. They would think I was a moron if they knew I had done 
that and needed PEP. 
45 years old, GUM, London
The majority of those who had taken PEP balanced their own support needs in social and work 
settings, with their desire for privacy about being involved in sex that risked HIV exposure. Many 
told a few friends, and a small number said they told everyone in their social network. Social support 
was certainly an important reason for telling others but frequently closest friends were the only 
members of an individual’s social network who knew. Most of those who had regular sexual partners 
at the time of the incident told them about being on PEP and the incident that had precipitated it. 
In some cases of sero-discordant relationships, the sexual partners themselves were the source of 
the exposure and had supported respondents throughout the entire process. However, one man 
described falling out with his partner because he had sought PEP. He had been accused of being too 
quick to act out his concerns about exposure, and the partner had felt blameworthy as a result. Two 
men decided not to tell their long-term partners about being on PEP. One said that it would have 
been too diﬃcult to manage within the context of their long distance relationship, and that nothing 
would be gained by disclosing. The other said that he could not risk the loss of the relationship, as 
acknowledging needing PEP would be an admission of inﬁdelity. 
It was very uncommon for men who had been on PEP to tell family members. One man who was 
living with his mother at the time decided to tell her that he was on PEP because he ﬁgured the 
medications would be too diﬃcult to conceal. However, he managed the situation by telling her 
he had been exposed to a stranger’s blood while helping out at an accident scene, rather than 
revealing that he was engaging in sex with men.
Only three men informed their GP about having been on PEP, and one of these had ﬁrst gone to 
his GP for advice following the sexual exposure incident. Another man described telling his new 
GP about his experience after moving to a diﬀerent city. In this instance, he was able to share this 
information with a health professional in a clinical setting, but no one else.
Men who took PEP demonstrated a variety of approaches to managing disclosure in work and 
educational settings. Nine of the men found that being on PEP did not interfere with any of their 
responsibilities, so there was no reason for colleagues to know. Most said that their personal health 
did not concern their employer. 
A further nine men reported taking some time oﬀ from work or education due to side eﬀects and / 
or follow-up appointments. With the exception of one man who worked in the HIV ﬁeld they did not 
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feel that they could be honest with their employers, colleagues or course leaders about the reasons 
for their absences. Often they gave other alternative reasons for missing work (such as stress). 
It is not really something you want to go around spreading to everyone. 
34 years old, GUM, Midlands & Eastern
The remaining four men did tell their employers or co-workers about the situation despite not 
needing to take time oﬀ. These men described their disclosure as a preparatory measure, in case 
they were going to need time oﬀ, reduced work-load, or physical assistance. All were happy with 
their decision to disclose, despite the fact that their physical health did not deteriorate dramatically 
as a result of being on treatment. One respondent commented that some colleagues had been 
rather ‘old-fashioned’ and ‘formal’ in their response, but he felt that if the situation were to occur 
again, they would manage it more appropriately.
One respondent who had been inappropriately refused PEP said that the interview was the ﬁrst time 
that he had told anyone at all about his experience. We must recognise that for some men, others’ 
knowledge of them taking PEP, or even having sought it, is considered stigmatising. 
3.5.2 Post PEP HIV testing
The majority of men who had taken PEP ensured that they undertook all of the recommended HIV 
tests following on from their exposure incident. Most reported a schedule that included antibody 
testing at the end of the treatment period, three and then six months later. Some men who had 
completed the treatment within a few months of the interview were anticipating attending their 
remaining tests. A few mentioned that rather than having appointments or being sent reminders 
for subsequent HIV tests, the treating clinic had simply advised them of a recommended testing 
schedule. Such an approach makes it impossible for retrospective eﬃcacy studies to be carried out. 
Six of those who had been prescribed PEP did not test at the recommended three and six month 
intervals (although two tested some time later). Men who did not follow-up with their HIV testing 
immediately after taking PEP tended to report a psychological need to ‘move on’ after taking the 
medication. They had felt traumatised by the experience of having to admit to health professionals 
that they had participated in sex that involved potential HIV exposure, and tended to interpret PEP 
as a ‘punishment’ for their behaviour. As a result, they preferred to try to forget about PEP as soon as 
possible. 
Once it was over it was over I closed the door on that particular incident.
29 years old, A&E, London
One man made a very prescient observation about the ambivalence with which he regarded 
coming to the end of this treatment regime.
Towards the end of taking the medication I actually got quite nervous that it wasn’t going to 
work. I thought, ‘I can’t wait until this stops’, but then also, I didn’t really want it to stop.
Because then you ﬁnd out?
Exactly.
34 years old, GUM, Midlands & Eastern
There can be little doubt that for some, anxiety increased toward the end of the treatment regime. 
As we have seen, the ‘moment of truth’, symbolised by follow-up HIV testing, was sometimes too 
much to bear. Without support, a minority simply chose not to ﬁnd out.
Of the thirty men who took part in this study, four were ultimately given an HIV positive diagnosis. 
The circumstances of one man’s story (detailed in case study #2 in section 3.3.2) suggest his sero-
conversion might have been avoided if he had been prescribed PEP when he sought it. Another 
man tested HIV positive three months after completing a course of PEP. He felt that the treatment 
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did not prevent his sero-conversion, but he still recommends PEP for others. The two remaining men 
with HIV attribute their infection to exposure that occurred after they completed PEP. 
3.5.3  Impact on future risk
As outlined in Chapter 1, the extent to which the possibility of the provision of PEP following sexual 
exposure might impact on future sexual risk behaviours has generated a signiﬁcant amount of 
academic and clinical debate. 
None of the men in this sample reported that the experience of seeking or taking PEP had increased 
the extent to which they participated in activities that risked HIV exposure. Most described the risk 
as outside of their normal parameters of safety and acceptability and did not expect to risk exposing 
themselves to HIV again (although some said that they could not rule this out). Other men felt that 
their HIV-related risk awareness had been heightened or reinforced by their experience of seeking 
or being informed about PEP, even where they had been cautious in the past.
It’s at the fore... at the front of my mind, I would always take precautions now. I mean, I was 
always very good before, but then I am just a lot more aware now. But it also makes me think, 
you know, people who are HIV positive and have to take medication such as this, just the hell 
they must be going through. Because, at least, you know, after a month that was it for me. So 
as well as, you know how it has aﬀected my personal outlook on safe sex, I think it is also, you 
know, awareness of HIV more broadly.
34 years old, GUM, London
Quite a few men who described themselves as having had a somewhat cavalier approach to HIV risk 
before their experience with PEP, found that having to undergo assessment and medication had 
dramatically altered their attitudes.
It certainly opened my eyes to it. I mean the fact that I am gambling with my life, possibly, 
you know. No one wants to die prematurely. So it made me think, ‘well hold on’. We all like to 
think we are immortal, but this kind of thing makes you realise that you are not. It is a bit of a 
wake-up call, really. 
30 years old, GUM, London
Of the ﬁve men who had sought PEP on more than one occasion, none thought of PEP as an ‘easy’ 
way to manage exposure situations. Rather, PEP was regarded as a serious ‘last resort’. Some of the 
incidents that led these men to seek PEP on more than one occasion included: condom failures 
with partners of known positive and unknown status; exposure of broken skin to the bodily ﬂuids 
of a known HIV positive partner; mucosal exposure (via the eye) to semen of a partner of unknown 
HIV status; and exposure of unbroken skin (near but not in the anus) to semen of a partner of 
unknown HIV status. None of these are the types of exposure situations might be characterised as 
demonstrating systematic problems with managing risk. 
If you do have an accident it doesn’t have to be the end of anything. Accidents will happen, 
condoms will burst, whatever.
39 years old, GUM, South
Of the two men who sought PEP more than once as a result of separate incidents of receptive 
unprotected anal intercourse, one expressed a desire for support to change his behaviour while the 
other was certain that it would never happen again.
3.5.4  Spreading the word about PEP
It is worth noting the extent to which accessing PEP has prompted some men to educate others 
about the treatment. Six men had engaged in discussions with others about PEP because of their 
belief that more people needed to know about it, and because they felt it should not be regarded 
as a simple ‘morning after’ solution. A few had supported and advised friends and acquaintances 
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following a potential sexual exposure. Another said that while he did not feel comfortable telling his 
friends that he had needed PEP, he had purposefully started to introduce the topic among those in 
his social network. 
One man talked of the ways in which men communicated with each other online about their 
experiences of being on PEP. He felt that this contributed to an overall increase in awareness and 
clarity about what treatment actually involved.
I think it’s really important for people to realise, you know, we all shout about PEP and it’s all 
very glossy. You know, the images THT put out with their ﬁre extinguishers make it sound 
like an emergency thing, and you know, one squirt of the hose and it’s all over. When it just 
fucking isn’t. It isn’t like that. And I spoke to quite a few guys that have actually had PEP and 
it’s deﬁnitely had a massive impact on their sexual health risk taking as a result of it. I think 
they are more conscious and aware of... they are less likely to put themselves at risk. 
40 years old, A&E, Midlands & Eastern
Some were critical of the way that the PEP message had been handled, embarking on their own 
promotion of PEP because they felt that not enough had been done by voluntary and statutory 
agencies to ensure that those at risk of HIV transmission knew about it.
I went on a sort of crusade after that, to let more people know about it, because I thought, 
‘well Christ, I am 29 years old, which isn’t necessarily old, but I’ve been on the London Gay 
scene since I was about 13. I know a lot of people, and I’ve known a lot of things, and I 
thought I knew a lot about being a Gay man. I did not know about this.’ And with hindsight, 
now, I‘ve thought, ‘Christ, the times that I could have recommended this to other people! 
How beneﬁcial it would have been for them’. In many ways, although it was an experience to 
go through, it has – even now, even with one of my brand new friends, I basically took him 
down to the local clinic, and bang, he’s on it at the moment. And even him, he didn’t know 
anything about it. So although I have seen a lot more advertisements and things like that, I 
just don’t think it’s bold enough. 
29 years old, GUM, London
3.6  SUMMARY & DISCUSSION
It’s worth considering the means by which the men in our sample came to know about PEP. A third 
of the sample had heard about PEP through social and sexual networks and the remainder came to 
know about it through the (Gay) media. This suggests that knowledge of, and conversation about, 
PEP may be common in certain social or friendship groups. While the processes by which PEP-
related information is diﬀused in such networks is not described here, it is important to recognise 
that social networks and health professionals have a key role to play in spreading PEP awareness, 
both before and after risk incidents occur.
The sexual incident that leads to men seeking PEP is described as an aberration from ‘normal’ sexual 
practice and the experience of taking PEP is usually an attempt to regain control over sexual risk. 
This ﬁnding has two implications. First, many of those who seek PEP are fully aware of the sexual 
risks they have taken and are prepared to act where HIV exposure may have occurred. They are not 
indiscriminate risk-takers. Second, they are using PEP as more than a clinical intervention. There is 
a broader symbolic meaning to seeking and taking PEP in which the individual takes responsibility 
and resumes control. This is important because the action of seeking PEP occurs at a time where 
men are forced to reﬂect on their sexual lives and their sexual risks. This may be the prime time to 
oﬀer such men a more structured intervention to facilitate this reﬂection.
As we might expect, the experience of seeking PEP is inﬂuenced profoundly by the quality and 
receptiveness of both information and clinical services. The experiences recounted here illustrate 
a need to assess and if necessary, to improve information services about PEP. Some men relied on 
existing contacts (such as a positive partner or friend) to gain access to clinics but the majority 
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found that they needed signiﬁcant personal resources, a capacity to advocate for themselves and a 
degree of persuasiveness to deal with frontline staﬀ (nurses and receptionists) who were ignorant 
of PEP, or doctors who were either unaware of PEP or unwilling to prescribe it. Moreover, men found 
themselves having to negotiate complex treatment and prescribing pathways at moments where 
time was critical. The social capital that underpins this capacity is more common among better 
educated men or men with higher incomes or from certain professional backgrounds. It may not be 
an exaggeration to say that at present, whether or not you get PEP depends largely on who you are, 
where you live and who you know.
However, not all of the men’s experiences of accessing PEP were negative or diﬃcult. Some received 
an exemplary service from the start and for many, when they ﬁnally found a receptive service, 
they were reasonably satisﬁed. It is perhaps worth learning from these examples of good practice. 
A successful outcome is one where a man either receives PEP or not based on appropriate risk 
assessment, is treated at all times with respect, and is referred for ongoing support where necessary.
The experiences of the men in our sample show highly variable practice around initial assessment, 
HIV testing, information and support, after-care and follow-up. This impacted profoundly on the 
quality of men’s experiences of taking PEP. What men valued most, both at follow-up and during 
initial assessment was that all staﬀ in the clinical environment demonstrated professionalism, and 
that doctors had access to expertise and knowledge regarding PEP prescribing, side eﬀects and 
adherence.
For some men, the social eﬀects of taking PEP were signiﬁcant. It is clear that there is a great deal of 
stigma attached to taking PEP. This has two causes. First men feel that their identity as responsible, 
self-reliant or prudent is compromised by having to take PEP. Second, talking about taking PEP 
mobilises knowledge about intimate sexual practices. In this sense, taking PEP was often seen as 
a personal or private matter. Like many areas where stigma is perceived, men reported balancing 
the need for social support and respite with the need to tell others about taking PEP. Men had a 
variety of ways to manage this tension. We recorded few diﬃculties in this respect. However, in 
view of the general resourcefulness of the men in the sample as well as their professional and 
social backgrounds, it is likely that they are able to manage such situations. It may be more diﬃcult 
to manage information around taking PEP in diﬀerent work or domestic environments or indeed 
where there are other social or personal co-factors (other health concerns, a chaotic lifestyle, or a 
shared household).
None of the men in our sample described PEP as an easy option and certainly none felt that the 
availability of PEP was likely to make them more likely to take risks in the future. Rather, for many, 
the experience of taking PEP was not something they would ever want to repeat. Therefore many 
spoke about how the experience might make them more careful in the future. However, in view of 
the proportions of men who sero-convert after taking PEP and those who have taken PEP on more 
than one occasion, it is clear that we need to know more about the sexual behaviours of men who 
take PEP (both before and after accessing treatment). Such investigations would contribute to  
the design of preventive interventions to be made available during and after men’s experiences  
with PEP. 
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Conclusions and 
recommendations
We structure our conclusions and recommendations into two areas. First, who is seeking, accessing 
and taking PEP and second, the experiences of those who try to access PEP. 
4.1 WHO KNOWS ABOUT, IS SEEKING AND GETS PEP?
Chapter 2 makes a distinction between awareness of PEP, ever having sought PEP and ever having 
taken PEP. As PEP is a relatively new technology or intervention, clear aims should be set with regard 
to awareness of PEP, seeking and receiving it.  
As regards awareness, our aim should be that all homosexually active men are aware of PEP. The 
change data from 2003 to 2005, presented in Chapter 2, indicates that although awareness has 
increased overall, it is by no means at saturation and demographic diﬀerences are evident. With less 
than saturation awareness of PEP, an interim aim might be that men more likely to be involved in 
HIV exposure should be more likely to be aware of PEP. Overall this is the case, with the exception 
of Black men and men with lower income (White other men remain more aware of PEP while men 
with higher income are more likely to be aware of PEP than men with lower income). However, these 
diﬀerences should not distract from the overall aim which is to make PEP awareness universal. That 
is, we should be seeking awareness among all homosexually active men. 
As regards availability of PEP, we should be aiming for a similar parity. That is, all men should have 
PEP equally available to them. The ways in which ‘equally available’ are deﬁned is open to question. 
It is perhaps inevitable that a man in central London will always ﬁnd PEP more easily available than 
a man in a small town or rural area. It might be more realistic to deﬁne a minimum availability that 
all men should expect – regardless of area of residence or other factors. The interventions needed to 
make this happen are likely to be structural and policy oriented. 
As regards seeking and successfully getting PEP, our aim should be slightly diﬀerent. On an 
individual level, our aim should be that any man who believes himself to be uninfected that is 
involved in possible HIV exposure seeks and gets PEP if he so wishes and if it is clinically appropriate. 
However, on a population level, we should expect the demographic proﬁle of men who seek and 
get PEP to be similar to those most likely to be involved in exposure (that is, men under 40, men 
living in areas where HIV prevalence is highest, Black men, men with lower incomes, exclusively 
homosexually active men and men with higher numbers of male sexual partners). Here the match 
between those currently seeking and getting PEP and those who we would aim to do so is more 
complex. While men living in London, men who have tested and men with higher numbers of male 
partners are more likely to seek and take PEP, those with higher incomes are also more likely than 
those with lower incomes to seek and take PEP. Moreover, men with higher incomes who seek PEP 
are more likely to actually get it.
The importance of this ﬁnding cannot be underestimated because it points to overarching pre-
existing social factors which threaten the success of PEP on a population level. Undoubtedly, clinical 
need will be the prime factor inﬂuencing PEP take-up (in the sense that all those who seek PEP 
have self-identiﬁed as needing an intervention of some kind). However, self-identiﬁcation of need, 
awareness of PEP and capacity to seek out PEP will not be equally distributed across the population. 
Those taking up complex medical interventions are generally more likely to be from class and 
cultural backgrounds possessed of greater social capital, especially if seeking and obtaining 
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interventions depends to a large extent on self diagnosis, motivation to actively seek help and 
overcoming clinical and social barriers to obtaining help. To put it simply, men seeking and getting 
PEP are currently more likely to be White, middle class, better educated and higher earning and 
therefore do not ﬁt the demographic proﬁle of the group most likely to be involved in HIV exposure. 
These ﬁndings are backed-up by the qualitative data which shows that often, requesting a highly 
specialised treatment (such as PEP) in a generic clinical setting (such as an A&E department), when 
such a request is likely to require a signiﬁcant amount of explanation and description, demands a 
patient who is prepared to invert the traditional power relationship with his health care providers. 
To a certain extent this is also true when confronting ignorance about PEP among NHS reception 
staﬀ.
When we regard the men who took part in qualitative research in these terms, we recognise 
their unique position at the forefront of PEP adoption and we are forced to conclude that it is 
unrealistic to expect that, with enough publicity, all men who are in need of PEP will already have 
the skills to access it. Interventions are therefore required to increase personal capacity (perhaps 
by increasing knowledge about rights to treatment or providing some form of advocacy service) 
while simultaneously working to remove the barriers to access encountered. Owing to a research 
design that did not recruit men directly from clinics where they had received PEP, this qualitative 
work brings with it the unique perspectives of men who were inappropriately denied PEP. Their 
experiences underscore the signiﬁcant ﬁnding that simply knowing about PEP and going out to 
access it is not always enough to get it, even when it was clinically appropriate. 
What this data highlights is that there is a need to ensure equitable access to PEP for those 
homosexually active men in greatest need. The CHAPS PEP campaign has successfully increased 
awareness and probably increased uptake among certain groups. However, the majority of media 
interventions appear to disproportionately beneﬁt middle class men, who are also more likely to 
pick up the information from magazine articles and editorials that mass media adverts generate. 
This means that these interventions, while beneﬁting the entire population, actually increase 
inequalities in access to interventions, and can increase inequalities in HIV incidence across income, 
class and ethnicity. Ensuring all men beneﬁt from emerging prevention interventions is a priority for 
all programmes and researchers. 
Speciﬁc interventions also need to continually improve men’s knowledge about PEP as well as their 
ability to access appropriate risk assessment and (where necessary) treatment. For instance, the 
men in this sample demonstrated that even where they knew about PEP in advance, not all were 
aware that treatment eﬀectiveness was improved when PEP was started as soon as possible after 
exposure. Careful consideration needs to be given to how best to communicate the message that 
PEP is available within 72 hours of exposure while also emphasising that men should try to access it 
as soon as possible. 
Thus, we might consider attending to the following in subsequent PEP interventions:
• the need to increase awareness of PEP further among Gay men generally; 
• the need to increase the availability of PEP generally; 
• the need for interventions to increase awareness (and uptake) of PEP among those homosexually 
active men more likely to be involved in exposure with less social capital (especially Black Gay 
men and men with lower formal education and income). 
4.2 THE EXPERIENCE OF SEEKING AND TAKING PEP
Our ﬁndings on the experiences of accessing and taking PEP provide us with insights into the way 
that PEP is perceived and used. We can now make a distinction between PEP as a straightforward 
clinical intervention (assessment, testing, diagnosis and prescription) and PEP as it is experienced 
by the men who seek and take it (as an event with long-lasting emotional, psychological and social 
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signiﬁcance). Attending to this latter conception of PEP allows us to envisage a range of social, 
psychological and interpersonal interventions that relate to taking PEP.
Our quantitative ﬁndings alert us to a need for a range of interventions which address the 
subsequent risk behaviour and support issues for those who present for PEP. As PEP is needed by 
men at highest risk of HIV infection, it should not surprise us that some of the men who take PEP 
subsequently go on to become infected with HIV (either through the failure of PEP or as a result of 
subsequent exposure). Men who have taken PEP in the past are still at signiﬁcant risk from HIV and 
taking PEP alone may not reduce this risk (Grulich et al. 2006).
In itself, prescribing PEP cannot be seen as a long-term behavioural intervention. Such an 
expectation chimes too closely with the attitude demonstrated by the doctor who said to one 
respondent, ‘Well, you won’t be doing that again, will you?’ and is hardly consistent with health 
promotion in the context of Making it Count (Hickson et al. 2003a). Instead, a more useful approach 
is to regard the event of seeking PEP as providing a unique opportunity where men may be open 
to reﬂecting about their sexual practices and risk reduction strategies and what might ‘go wrong’ 
during sexual negotiation. In our qualitative research, men described the moment of seeking PEP 
as a unique event in their sexual lives commonly characterised as the result of a temporary loss 
of control over sexual risk and a need to regain this control. This experience is echoed in research 
elsewhere (Körner et al. 2003, 2005). In short, this may be an appropriate opportunity to undertake 
tailored and sometimes in-depth interventions with men who are involved in exposure to HIV. 
As such, the clinical intervention’s unforseen eﬀect (of restoring a feeling of control) might be 
augmented and signiﬁcantly enhanced by a complementary intervention supporting those with 
behaviours that carry a high risk of HIV transmission (Roland et al. 2005).
The need for such an intervention becomes compelling when we consider that the population 
of PEP seekers are men who have been involved in possible HIV exposure. As PEP becomes more 
widely sought, it is likely that this population will increasingly approximate the population of men 
most likely to be involved in HIV exposure and sero-conversion. Moreover, health promoters have 
access to this group at a time when they are amenable to reﬂecting on their sexual practices. What 
this suggests is that PEP services should, wherever possible, refer clients to HIV prevention services 
that could meet their other HIV prevention needs perhaps via a tailored psycho-social intervention. 
Allied to this need for interventions accompanying PEP assessment and prescription are a range 
of concerns about improving treatment protocols for PEP. The experiences of those taking PEP 
examined in the qualitative research indicate not only that there is patchy follow-up care and 
support, but also that baseline testing for HIV as well as three and six month follow-up tests are not 
consistent. Finally, there is little monitoring of men’s sexual risk behaviour post-PEP nor any longer-
term support. This is inappropriate because it impacts negatively on men’s experiences of taking 
PEP and it precludes the possibility of developing proper follow-up protocols for this application of 
PEP. 
Our qualitative investigation suggests shortfalls in the standards of services both from advice and 
information services as well as some A&E and GUM clinics. Interventions both to improve services 
and enable users to deal with their variable quality might include training and development for NHS 
staﬀ about PEP – with a distinct component focussing on frontline and reception triage routines in 
such circumstances. In addition, advocacy with individual clinics about developing their own PEP 
treatment protocols and communicating these to clinical and non-clinical staﬀ may be appropriate. 
Finally it may be important to provide information to homosexually active men, not only about 
what they can expect from providers, but also ways in which they can either demand PEP or enable 
providers who do not know about PEP to ﬁnd out about it and administer it.
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4.3 SERVICE RECOMMENDATIONS
4.3.1 Direct contact interventions for homosexually active men
Although we have highlighted diﬀerences in the demographic proﬁles of those who seek and 
receive PEP, it will be diﬃcult to address them until we have reached a point of population 
saturation as regards awareness of PEP. We therefore recommend that in the short-term, 
interventions to increase PEP awareness should be prioritised over interventions to change the 
demographic proﬁle of those who seek and receive PEP.
• Continued general PEP awareness campaigns for all homosexually active men are required. They 
should make it clear that the sooner PEP is sought after possible exposure, the better. 
• Targeted PEP campaigns are required for men who are currently less likely to know about PEP. 
• A range of information, support and psycho-social interventions are required for all men seeking 
PEP, including those who do not receive it.
• An information intervention enabling men seeking PEP to present to clinics more eﬀectively and 
demand PEP if necessary (eg. information / activist cards).
4.3.2 Sector development interventions
The Chief Medical Oﬃcer has stressed that PEP should be a part “of the spectrum of sexual 
health services” in all Primary Care Trusts (Donaldson 2006). Uptake and implementation of 
this recommendation requires a variety of actions from a range of organisations including the 
Department of Health, Primary Care and other NHS Trusts, Strategic Health Authorities and 
voluntary and community organisations. These include: 
• Develop and implement PEP information services and training protocols for all service providers 
(including A&E staﬀ and NHS Direct). For example, some countries have implemented PEP 
helplines for medical staﬀ who are unsure of protocols or prescribing criteria. Given the likely 
information needs among non-HIV specialist staﬀ such an intervention could be considered for 
the UK.
• Monitor and seek to improve individual A&E and GUM clinics’ PEP protocols. Such protocols must 
attend to the way in which triage, reception and clinical staﬀ handle those who seek assistance 
after a potential HIV exposure. Such protocols should also attend to the need for conﬁdentiality, 
sensitivity, referral pathways, informed consent for HIV testing, and provision for HIV testing at 
three and six months following potential exposure.
• Work to ensure the development and/or implementation of appropriate follow-up protocols for 
those who present with a request for PEP, including direct referral pathways from A&E settings 
into specialist GUM and HIV care.
• Consideration should be given to the need for STI screening and counselling for those who do 
not receive PEP treatment. 
• Adherence and related social support should be available for all those who receive PEP. These 
should be oﬀered not only at the start of treatment but also towards the end, given that 
adherence can decline as individuals become either more anxious or less concerned about 
eﬃcacy.
• Men who indicate a high level of pre-existing sexual risk behaviour should be referred to tailored 
behavioural interventions – either delivered by clinical psychology departments associated with 
the treating clinic, or by appropriate voluntary and community sector organisations.
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